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An Evaluation of the Physician Orders for Life-Sustaining Treatment (POLST) Program 
Aluem Tark 
 
The number of elderly in the U.S. (i.e., individuals age 65 years or older) is growing at a 
rapid rate.1-4 While the current proportion of elderly persons living in U.S. is estimated to be 
little over 14%, it will soon reach up to 20% in next 10 years.5,6 In addition, it is anticipated that 
the elderly population will soon outnumber the younger generations, for the first time in U.S. 
history.2 
With the rapid shift we are witnessing in the U.S. population, the World Health 
Organization (WHO) informs that the leading cause of death in U.S. has also shifted: from 
infections to chronic illnesses.7 The majority of elderly individuals will suffer from at least one 
chronic illness, and many will live longer than ever, with complex multiple healthcare needs.8-11 
The demands for specialized end of life (EoL) care among frail elderly will continue to rise,12,13 
and it is among the top research priorities to identify best practices in EoL care and understand 
how best to facilitate patient-centered care in healthcare settings.  
In order to increase awareness in the importance of quality care provided to those who 
are near EoL, the Institute of Medicine (IOM; now the National Academy of Medicine) 
recommended a nation-wide implementation of an advance care planning tool, the POLST 
(Physician Orders for Life-Sustaining Treatment).14,15 Designed specifically for frail individuals 
living with serious illnesses,16 the POLST program is used to elicit care preferences and deliver 
goal-concordant care. Making patients’ specific care wishes actionable and transferrable, it aims 




evaluate the POLST program, from its effectiveness, dissemination, to outcomes associated with 
its maturity status.  
The first chapter provides background information on the aging population the 
importance of advance care planning among frail elderly persons. The POLST program is 
introduced and I lay out the three research aims and the significance of each topic. Chapter 2 
contains a systematic review of scientific evidence on the concordance between documented care 
wishes and actual care delivered to the POLST users. It explains specific care interventions that 
yielded high concordant care, as well as ones that had mixed results. In chapter 3, an 
environmental scan of a state-specific POLST program across all U.S. states and Washington 
D.C. is presented; the scan examined maturity status, specific care options mentioned/ absent as 
well as descriptive statistics on the association between presence of infection/pain-related care 
options and the POLST program maturity status. In chapter 4, a quantitative analysis aimed at 
examining the impacts of the POLST program maturity status on a patient-level outcome (i.e., 
nursing home death) is presented. In it, multiple large datasets were used to generate a 
representative sample of the U.S. nursing home population. I then applied multivariate logistic 
regression modeling to estimate associations. Lastly, chapter 5 synthesizes the findings of this 
dissertation as well as strengths and limitations. It then shares recommendations for policy, 
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Chapter 1: Introduction 
 
Chapter one consists of background information regarding the growing aging population 
and advance care planning. After discussing shortcomings of current advance care planning 
tools, the Physician Orders for Life-Sustaining Treatment (POLST) paradigm program is 
introduced. The current status of end-of-life care provided in long-term care settings is also 
described. The three research aims, the significance of each topic, the conceptual underpinnings, 







The average human life expectancy is increasing and this is a global phenomenon.21,22 
According to the World Health Organization (WHO), human life expectancy has increased from 
64 years to 70 years, between the years of 2000 and 2016.23 This is thought to be the fastest 
growth observed by far, potentially bringing multiple challenges in provision of healthcare, 
especially for those who are now living longer, with multiple health issues.24 In the U.S. alone, 
the average life expectancy is reported to be higher than the global average (i.e., reaching up to 
80 years), reflecting a rapid increase in the number of U.S. elderly (defined age of 65 years and 
older) persons.25 With this unprecedented growth, it is projected that there will be an important 
demographic shift in the U.S.; that is, in next 15 years the elderly population will for the first 
time in U.S. history outnumber those who are 18 years and under.26 Behind this fast-paced 
growth in the number of elderly persons stands two major events: the influx of aging baby 
boomers, and continued advances made in medical technologies.  
The baby boomer generation first began turning age 65 in 2011, and this will continue for 
the next decade. By 2029, all baby boomers will be in the elderly group, constituting over 20% 
of total U.S. population.19 Frailty, defined as the consequence of accumulated age-related defects 
in physiological symptoms, is thought to be among the most commonly encountered health 
issues this generation will face, as consequences of population living longer with advanced 
illnesses and/or multiple co-morbidities.27  
Advances made in medical technologies have also contributed to the longer-than-ever 
human life expectancies. Innovations in biomedicine made an early detection of an illnesses 
possible, offering more curative treatment options, yielding a decline in overall mortality 




also inadvertently placed a heavy emphasis on cure of illnesses, rather than the care of 
individuals. It is not uncommon to witness terminally ill patients receiving highly aggressive and 
often futile treatments, especially when the patients’ End-of-Life (EoL) care preferences and 
wishes are unknown.30,31  
End-of-Life (EoL) Care and Advance Care Planning (ACP) 
EoL care is a term used to describe the physical, psychological supports and medical care 
provided to an individual during the time surrounding one’s death.32 It aims to relieve sufferings 
while improving quality of remaining life of an individual living with life-limiting, or terminal 
illness.33 Ideally, quality EoL care should reflect dying patient’s own values, beliefs and goals 
while respecting his/her autonomy in medical care decisions.34,35 One of the most critical 
elements in the planning and the delivery of quality EoL care is in the awareness and a shared 
understanding of patient’s specific care preferences.36 Without such information, medical 
interventions delivered at EoL were found to be more aggressive, geared toward the life-
sustaining purposes, and more likely to cause protracted death by default.37-40  
Advance Care Planning (ACP) is a process of discussing EoL care preferences between a 
patient and care providers, and formulate a future medical care plan.40,41 It can inform and 
empower patients of their rights to have their care wishes respected, even when the patient 
becomes unable to verbalize his/her own choices.33 Researchers have found positive associations 
between ACP and the quality of life in dying patients, and their family members. Specifically, 
ACP discussions have been linked with an increased concordance between treatments preferred 
and received at EoL, and decreased episodes of anxiety or depression reported among surviving 
relatives.35,40  
Living wills and the health care proxy are the two most frequently used legal documents 




written EoL care wishes, while health care proxy allows a dying individual to appoint a 
surrogate, who will make medical care decisions when the patient becomes incapacitated to 
make further choices.43-45  
Shortcomings of Advance Directives (ADs) 
It was in the mid-1960s when ADs were first introduced to the public. Developed by a 
human rights attorney, ADs were the first attempt in constructing a legal system that can help 
preserve the autonomy of incompetent medical patients.46,47 Soon after, the U.S. congress passed 
the Patient Self-Determination Act, which became a pivotal event in raising awareness of ADs 
among general population.48,49 Through the Patient Self-Determination Act, all U.S. health care 
institutions (e.g., Hospitals, Nursing Homes and Homecare Agencies) receiving Medicare/ 
Medicaid reimbursement were federally mandated to a) inquire about the presence of ADs in all 
adult patients, and to b) inform patients’ rights to formulate ADs for future care, if one has not 
already done so.48,49  
Nearly six decades after the birth of ADs, scientific evidence on the impacts of ADs 
(specifically, the roles it played in EoL care delivery) accumulated and the findings were 
mixed.50,51 While there were benefits associated with the use of ADs (i.e., improved care 
satisfaction),35,52 many researchers have also raised growing concerns on the limited use of 
ADs.44,45,53,54 In an earlier study, published in 1993, researchers found that the actual proportion 
of individuals who completed ADs were low; ranging between 20 and 30 percent.48,55-57 In the 
most recent studies, where researchers reviewed healthcare records from 2009 to 2016, similar 
findings were reported; completion rates were between 18 and 36 percent.55,58,59  
Moreover, other shortcomings of ADs were identified, which include: use of ambiguous 




condition); lack of transferability between care settings (e.g., hospitals to nursing homes); 
difficulty locating ADs under medical crisis, which led to unwanted care received; and limited 
scientific evidence supporting the effectiveness of ADs among frail individuals suffering from 
chronic, progressive cognitive illnesses (e.g., dementia).44,45,54,60-65 Low completion rate and a 
limited body of scientific evidence that ADs can enhance goal-concordant EoL care among 
vulnerable population motivated efforts to seek an alternate ACP tool that can potentially close 
the existing gap between EoL care preferred and care being delivered.45,55,62 
Physician Orders for Life-Sustaining Treatment (POLST) Program as a New ACP tool 
In early 1990s, a group of medical experts in Oregon convened to discuss a concern that 
the EoL care preferences of individuals living with frailty and/or serious illnesses were not 
consistently honored.66,67 With increasing scientific evidence showing low completion rate of 
ADs among frail individuals failing to ensure goal concordant care at EoL, a voluntary 
interdisciplinary task force (consisting of nurses, doctors and lawmakers) was formed to develop 
strategies to overcome such limitations.68 An initial version of a newly invented tool from this 
taskforce was called a Medical Treatment Coversheet.69 This was a single-page assessment of 
patient preferences for: resuscitation; level of medical services desired; antibiotics use; and 
artificial/ fluids and nutrition. After a successful completion of pilot studies in Oregon, this form 
was deemed feasible for the use within healthcare settings (i.e., clinical setting, and long-term 
care settings).67 After some minor revisions were made, this tool was re-named as Physician 
Orders for Life-Sustaining Treatment (POLST) and disseminated state-wide.70 By 2004, more 
than half of Oregon’s healthcare settings such as hospital and NHs implemented the POLST 




With a success of the POLST program witnessed in Oregon and a growing body of 
scientific evidence showing effectiveness of POLST use,72-75 interests to adopt POLST program 
in other parts of U.S. have also increased. To meet the needs and provide a framework for a 
state-specific implementation and dissemination of POLST, a group of experts from different 
states (i.e., Oregon, New York, Pennsylvania) formed a committee called the National POLST 
Program Task Force.18 Its members provided an on-going assistance with the program 
development, and acted as facilitators in the implementation of POLST programs in various 
states.18,67 Over the next decade, nearly 90% of U.S. states (n = 45) have either officially 
developed, or were actively developing POLST programs for their states.71  
There were a few characteristics and strategies that separated the POLST program from 
the existing ADs. For example, the POLST form was designed specifically for individuals living 
with serious illnesses or advanced diseases, for whom their care providers would not be surprised 
if a patient died within a year.19 A close proximity between the time of EoL care planning (i.e., 
POLST form completion) and the actual time of death, offered an important opportunity to 
discuss and formulate a care plan, in light of patient’s current medical condition(s). That is, 
rather than using a hypothetical situation as the basis of future care decisions as in most ADs, the 
POLST program introduced a here-and-now approach in EoL care planning.65 In addition, the 
POLST form was designed to act as a vehicle that can facilitate important care discussions 
between a care provider and a dying patient.72 Whenever the POLST form was used for ACP, it 
was mandated to document patient preferences for cardiopulmonary resuscitation, preferences 
for artificial nutrition administration and identify specific levels of care a dying patient wishes to 
receive (i.e., comfort-only, limited interventions only or full interventions for life-sustainment.65 




expert, rather than a legal expert (e.g., a lawyer), was an added advantage of the POLST form; 
when the questions arose during EoL conversation, medical experts were able to clarify or 
answer based on medical knowledge.76   
Upon completion of a POLST form, patient’s documented care wishes become a set of 
medical orders. By converting care wishes to a set of transferable and actionable medical orders, 
discordant care or unwanted interventions could be avoided. In some states (i.e., Oregon, West 
Virginia), POLST forms can be accessed through a state-wide electronic database, giving an 
opportunity for any healthcare providers to gain immediate access to patients’ care wishes when 
needed across settings.20,76 This was a particularly important step in ensuring patient-centered 
EoL care for elderly and frail individuals as they are at a higher risk of experiencing unexpected 
medical emergencies toward EoL.77,78 First responders (e.g., emergency medical technicians and 
paramedics) arriving at the scene were able to access  e-registry and identify the presence of 
POLST documentation, giving them a chance to deliver specific interventions that reflect  
patient’s wishes.79  
Nursing Home Use in Aging Population 
Historically, institutional settings where services and supports are provided to help frail 
individuals and/or older adults with their daily activities were referred to as long-term care 
setting.80 This is now used as an umbrella term, which includes: non-acute health care facilities 
such as adult day service center; home health agencies; residential care/ retirement communities; 
and nursing homes (NHs).81 The latter also referred to as skilled nursing facilities, differ from 
other types of long term care facilities as its residents receive a continuous nursing care (i.e., 24-
hour-a-day basis), either on a short term (e.g., post-acute rehabilitation) or long term basis.82 




In recent studies on U.S. long term care services and its use, it was indicated that NHs 
had the largest shares of services users, nearly 1.5 million U.S. residents annually.83,84 While 
90% of these NH residents are aged 65 years and older, the oldest-old (i.e., age 85 years and 
over) represent more than half of all NH residents across the nation.84 It is noteworthy that NHs 
are now at the forefront of delivering medical care to those who are vulnerable, frail, 
approaching EoL, and most often suffering from advanced/serious illnesses. A large body of 
scientific evidence shows that nearly 70% of all U.S. individuals living with an irreversible and 
progressive brain disorder (e.g., dementia, Alzheimer’s disease), or a progressive 
neurodegenerative disease (e.g., Parkinson’s disease) receive their care in NH settings, and even 
more likely so in the advanced stages of terminal illnesses.85-87 
Nursing Homes and End of Life (EoL) Care  
With a growing evidence that a) the NHs are important care settings for aging population, 
and b) demands for quality EoL care will continue to rise, it is critical to understand the current 
status of EoL care delivery in U.S. NH settings. Unfortunately, previous studies unanimously 
reported that the majority of NH residents are not receiving any formal EoL care (i.e., hospice or 
palliative care), even when they were eligible for receiving such services, based on their illness 
trajectories or limited life-expectancies.88 Although it is well established that physical and 
psychological burdens increase drastically as one approaches EoL, the quality of care provided to 
the dying patients in NHs still remain sub-optimal.85,89,90 In fact, it has been reported that a high 
number of NH residents were subjected to inappropriate EoL care practices and patterns; 
especially in their final months of life. Such findings were supported by poorly managed 
physical symptoms reported in the last month of life, frequent care transfers from NH to acute 
care facilities (e.g., emergency departments, intensive care units), which were deemed 




To address a growing concern of sub-optimal EoL care, and to raise awareness on 
importance of symptom management near the EoL, the Institute of Medicine (now called 
National Academy of Medicine) released a set of recommendations for the care of individuals 
approaching death.94 In these recommendations, palliative care was described as a highly 
effective care model, which helps to achieve the highest possible quality of life for individuals 
who are living with serious illnesses.94 With emphasis on an urgent need for an ACP tool that is 
communication-based and patient-centered, these recommendations included a call for the 
nation-wide implementation of POLST programs in hopes of shifting the paradigm in U.S. EoL 
care system.95  
Infections at the End-of-Life (EoL) 
 Along with physical sufferings, infections are among the most commonly encountered 
health complications at EoL.96 Decreased immune functions, comorbidities and functional 
impairments such as urinary incontinence contribute to increased risk of infection among elderly 
NH residents.97 Infection management in NH settings can be particularly challenging as this 
population tends to exhibit atypical and/ or non-classical signs and symptoms.98,99 Studies show 
that up to 30% of elderly persons harboring serious infections remain afebrile.98 Instead, non-
specific changes such as failure to thrive, confusions or falls have been reported as signs of 
infections.98 Combined with the fact that not all NHs are equipped with advanced technologies 
for early detection of infections, or have adequate resources readily available (e.g., in-house 
infection preventionist) for prompt consultations, high mortality and morbidity from infections 
are commonly observed.100,101 
  Infections at EoL remain as the primary reason for burdensome care transfers between 




hospital transfers within days of their deaths.77,105,106 Although scientific evidence supporting 
antibiotics use at EoL and health benefits in dying patients is lacking, care transfers due to 
infections are most commonly seen toward the EoL.97  Frequent disruptions in continuity of care, 
repeated exposures to invasive procedures, increased risk of iatrogenic complications (i.e., 
pressure ulcers, confusions, functional declines) or nosocomial infections pose multiple serious 
health threats to the quality of life among already-frail NH residents.107,108 
Significance 
Gaps in knowledge 
Although previously published studies have examined the effectiveness of the POLST 
programs, in terms of congruence between EoL wishes documented and honored, they were 
limited to a single institutional setting (e.g., hospice), 49,50 or a single state (e.g. Oregon).72,73,109 
The overall rate of congruence measured on a national level, across all different healthcare 
settings (i.e. hospice, hospital, nursing homes and community) is critical information, and yet has 
not been studied.  
The national POLST paradigm task force mandates that all POLST forms include 
elements that can elicit patient preferences for: cardiopulmonary resuscitation; artificial nutrition; 
and specific level of care (i.e., comfort only, limited care or life-sustaining care).110 Other than 
aforementioned elements, each state is allowed to include any EoL-relevant care options on a 
POLST form. A comprehensive examination of different types of care options presented in all 
POLST forms across the nation has never been conducted. A recent study of the POLST program 
and variations in POLST forms have only identified whether the mandated elements were 
present or absent.111 Moreover, POLST forms from developing or non-conforming status were 
excluded from their review. Breadth and depth of EoL care options captured in all available 




Furthermore, there is a need for examining whether a state-wide implementation of 
POLST program is associated with individual level outcomes. And if so, identify whether 
differences in individual level outcomes differ based on the level of POLST maturity status (i.e., 
Mature, Endorsed, Developing and Non-conforming; highest to lowest). Previous research work 
informed that when a well-structured care system is introduced to NHs, diffusion of new 
knowledge produces changes in practices and cultures within organizations. For example, when 
the specialized EoL care team or hospice program was introduced a NH, significant 
improvements in the rate of EoL hospitalizations,112,113 and the pain managements were noted 
throughout all NH residents (i.e., in both EoL care recipients and non-recipients).114,115 Little 
research has examined the state POLST program, and maturity-status associated outcomes in its 
residents. The third aim of this dissertation study fills in the gap through investigating 
differences in the POLST maturity status across the nation and associated outcome observed in 
residents. For frail elderly NH residents at EoL, an important outcome to assess for the quality of 
care received at EoL is a place of death,116-120 as hospitalization,92,121-124 death at intensive care 
units and frequent transfers between care settings are known to be burdensome, contradict EoL 
care wishes,  and cause discomfort needlessly.92,117,118 
Conceptual framework 
The conceptual framework guiding this dissertation is a modified Gelberg-Andersen 
Behavioral Model for Vulnerable Populations. (Shown in Figure 1.) This is a revised version of 
an original model, Andersen Behavioral Model, which is widely recognized as one of the most 
comprehensive conceptual frameworks in the analysis of healthcare utilization and access to 
care. 125-127  
The original version of the model was first introduced in 1960s in Andersen’s dissertation 




studying healthcare utilization. Discovery of large disparities in people’s access and utilization of 
healthcare services led him to develop the framework.128  In it, Andersen explains that the use of 
health services is a function of three determinant factors; predisposition to use services 
[predisposition], enabling or impeding factors for service usage [enabling] and the need for the 
care [need].129 Although the original model underwent numerous revisions to reflect evolving 
nature of research interests and changes in health care industry, the fundamental determinant 
factors (i.e., predisposition, enabling and need factors) remained unchanged.125,126 Andersen’s 
behavioral model for health services use is well-suited for this dissertation as it examines both 
contextual and individual factors that are associated with individual’s health behaviors and 
outcomes. 
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Predisposing factors  
 
Predisposing factors are variables that existed prior to the onset of illness. It can be 
characteristics observed from an individual, or environment or surroundings (e.g., contextual). 
Although these variables are not directly responsible for either the presence or the absence of an 
outcome, individuals with certain characteristics are more likely to utilize health services.130 For 
example, previous studies identified that certain individual characteristics are predictive of 
increased health services utilization; being older, married, and of a female gender has found to be 
positively associated with both access to, and cost of care.131-133 
As depicted in Figure 1, demographic characteristics (age, sex) and social structures 
(marital status, ethnicity) are included under predisposing factors. Contextual predisposing 
factors include sociodemographic characteristics of a community. The proportion of elderly 
population living in a county and metropolitan/urban status are two examples of contextual 
predisposing variables.   
Enabling factors 
Enabling factors include resources available from family, or community. Mean household 
income (financial resources) is one of a few examples that can either enable, or impede health 
services use.134 Community-based resources, such as available medical facilities within area, and 
NH-level characteristics (e.g., ownership type, chain membership status, and occupancy rates) 
can also influence the outcomes of service utilization. Previous studies identified that certain NH 
characteristics (e.g., availability of hospice program) were associated with increased use of 
health services.112,135,136  
Other important variables under enabling factors include information pertinent to 




research, it is known that the variations observed across different areas can play major roles in 
the rate of health services use including differences in number of hospitalizations or length of 
stay.138-141 For instance, Temkin-Geener and colleagues reported significant differences in 
location of death, and quality of care provided for dying patients between NH facilities located in 
either rural or urban areas.141 Crouch and colleagues have also noted significant geographic 
differences (i.e., rurality) associated with health services utilization and Medicare spending in the 
last six months of life in elderly patients.  
The POLST program characteristics (i.e., maturity status and the total number of years 
since the state obtained developing status) will be included under the enabling factors. The 
differences observed among state-specific POLST programs are the focus of all three studies. 
The possible associations between POLST characteristics and individual-level health services 
utilization/ outcomes will be explored in the third aim of this dissertation.   
Need factors 
Need factors include health conditions of an individual that is professionally evaluated, or 
self-reported/ perceived that are associated with healthcare utilization. It also includes 
individual’s functional abilities/ restrictions (e.g., activity of daily living) as well as physical and 
mental health status.142-144 In a recent study, Li and colleagues reported that the presence of 
chronic illnesses (e.g., stroke, diabetes, heart disease) were associated with increased healthcare 
utilizations; visits to physician’s office (both in/out patients settings), and the rate of 
hospitalizations.145 In the same study, it was also emphasized that the higher healthcare 
utilization was observed among the group who reported problems with their self-perceived 
health.145  




Andersen’s behavioral model is widely used in health science research, where researchers 
examined why and how we utilize health services. Previous studies indicate that there are 
different types of factors that can influence outcome (e.g., health services use), depending on the 
population of interest, health conditions or health services being studied.146 Individual or socio-
structural characteristics can predispose an individual’s likelihood of seeking services, while 
enabling play important roles in frequencies (e.g., routine visits) or modes of health services use 
(i.e., routine office or emergency room visits as needed). Lastly, different health care needs (e.g., 
medical conditions) can also be considered to explain, and predict likelihood of future use of 
healthcare services. In studies 1, and 3, different modes of health services use will be discussed. 
Specifically, different types of care services utilized (e.g., antibiotic treatments, or artificial 
nutrition) will be explored in the first study, while utilization of NH (versus other settings) at the 






Study 1: Synthesize the evidence on the congruency between Physician Orders for Life-
Sustaining treatment (POLST) documentation and subsequent care delivered to End-of-Life 
(EoL) for U.S. residents. 
A systematic review of literature was conducted to examine whether POLST users’ 
documented care wishes and treatment preferences were honored at EoL.  
 
Study 2: Examine current status of POLST program implementation across U.S. and identify 
state variations in how infection and physical symptom management options are captured on 
state POLST forms. 
 
An environmental scan was conducted to identify status of POLST implementation across U.S. 
settings, and then to examine treatment options mentioned on regional POLST forms.  
 
Study 3: Controlling for other contextual and individual characteristics, examine impacts of 
POLST maturity status on the place of death (i.e., Nursing Home death) among elderly 
individuals residing in U.S. nursing homes.  
 Hypothesis: Controlling for other contextual and individual characteristics, the higher 
maturity status is positively associated with NH reported as the place of death among long-term 
residents.   
 Primary data collected during our environmental scan was linked with:  NH resident level 
data using the Minimum Data Set 3.0 and Master Beneficiary Summary File; facility level data 
using Certification and Survey Provider Enhanced Reports; and county level data using Area 
Health Resource File to examine the place of death of the NH residents across the nation.     
Potential Contributions 
This research work contains comprehensive findings of the POLST program use and the 
associated outcomes in the national, state, facility, and individual-level. It carries multiple 
potentials to contribute to the body of health science research, especially in the issues 
surrounding advance care planning of frail and vulnerable population. The literature review 




and actual delivery of EoL care interventions. It offered new, and important perspectives on both 
strengths and weaknesses that the state-specific POLST forms may have, evidenced by high, or 
low rate of congruence reported in our findings. In addition, this review can serve as an 
evidence-based guidance should future modifications and revisions in POLST composition be 
called for.  
The findings from our environmental scan informed how infection management, and 
symptom management-related options were captured in all available POLST forms.71 It was the 
first study to offer a comprehensive look at similarities, and differences between state-specific 
POLST forms that are currently in use. Primary data collected through this work has potential to 
be served as important state-level variables in the future studies involving the POLST program. 
When merged with other national-level large dataset (e.g., MDS) the potential contributions to 
the body of science will be even greater.   
Examination of impact the POLST maturity status have on U.S. NH residents’ place of 
death identified an important association between the state participation of the POLST program, 
and individual-level outcome. Place of death is frequently studied quality indicator for EoL 
care,116,118 as death occurring in hospitals among frail elderly are linked with increased physical 
burden and diminished quality of life. Our findings have potential to influence state leaders and 
law makers to encourage implementation of well-structured ACP programs in U.S. states and 
continue to seek ways to enhance EoL care delivery system for all residents living with advanced 
illnesses.  
Lastly, our findings generated from all three studies carry potential to enhance quality of 
life, and EoL care journeys for individuals living with any types of physical illnesses, regardless 




advance care planning resonates dying patient’s specific care goals and remind encourages 
provision of high-quality medical care throughout all spectrums of life that every single 
individual deserves. It will become a solid foundational scientific knowledge that it is patient’s 









Chapter 2: Congruence between End-of-Life Care Preferences using Physician Orders for Life-
Sustaining Treatment (POLST) documentation and subsequent care delivered:  





The following chapter is a systematic review examining congruence between End-of-Life 
(EoL) care preferences documented using Physician Orders for Life-Sustaining Treatment 
(POLST) forms, and the subsequent medical care delivered to dying patients. This review 
followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement, and provided systematically, and critically appraised scientific evidence on the overall 
congruence rate of POLST sections: CPR documentation and resuscitation attempted, hospital 






Note: This chapter has been submitted for publication, and is currently under review for BMC 







Physician Orders for Life-Sustaining Treatments (POLST) paradigm is an advance care planning 
program that is designed to facilitate End-of-Life care discussions between a medical provider 
and a terminally ill patient living with advanced illnesses. With an increased utilization of the 
POLST program in various healthcare settings and continued dissemination across the nation, it 
is important to examine scientific evidence on the congruence between care preferences 
documented on POLST form and subsequent medical care delivered. 
 
Methods  
PubMed, Cochrane Library, Embase, and CINAHL databases were searched. Eligible articles 
were: written in English, conducted in U.S., used quantitative research methods and published in 
a peer reviewed journal. Two researchers independently reviewed eligibility of articles, extracted 
relevant data, and assessed study quality. The New Castle Ottawa instrument was used to assess 
the quality of evidence The PRISMA guideline was followed.  
 
Results  
A total of 8 studies met eligibility criteria. Four studies were retrospective cohort design, 2 were 
prospective, and the rest cross sectional. All studies used chart review methods; one study 
included interviews. In total, 19,504 POLST forms were compared with medical records. 
Congruence between CPR documentation and resuscitation attempted or delivered varied (range 
57% to 100%.) Preferences for hospital transfers were honored 90% of the time. Among those 
who opted no antibiotics, incongruent cases were found in 32% of forms. Wishes for limited 
antibiotics use at EoL were congruent with care delivered in over 90% of times. Use of feeding 
tube and IV fluids at EoL were congruent with written wishes in nearly 95% of cases. Quality of 
evidence was good in 6 and fair in 2 studies.   
 
Conclusions 
Resuscitation preferences documented on POLST forms were universally respected. Use of 
feeding tube or IV fluids at EoL showed mixed results. Additional research is recommended to 
identify congruence between POLST documentation and care delivered among patients who 
experienced multiple care transitions or have moved across state near the time of death.  
 
 









In 2014, the Institute of Medicine (now the National Academy of Medicine) released a 
consensus report, Dying in America, which raised an awareness on the importance of providing 
high quality end-of-life (EoL) care for those who are near death. In this report, appropriate EoL 
care was described as a vehicle that enhances quality of life for those who are near death, and as 
an essential factor to a more sustainable care system.15 One of the conclusions was that there was 
a need for further state-wide adoption and active implementation of the patient-centered and 
communication-based advance care planning program, most commonly known as Physician 
Orders for Life-Sustaining Treatment (POLST).15  
POLST was developed in early 1990s.65 It is a portable advanced care planning order set 
that facilitates EoL care discussions between a medical provider and a patient, with the goal of 
increasing the likelihood of EoL care delivery that aligns with patient’s values, beliefs, and goals 
of care. Although other advance care planning tools (i.e., living wills or health care proxy) exist, 
the POLST developers took a unique and enhanced approach. First, POLST was designed 
specifically for those who suffer from life-limiting illnesses and have a life expectancy of less 
than a year. Second, a completion of, or any revisions of POLST documentation require a 
treating practitioner’s involvement and the signature to be valid. This was to reinforce that EoL 
care discussions and subsequent decisions should be guided by a medical provider who can 
clarify ambiguous medical terms, answer any questions, and to provide insights on implications 
of certain treatments that a patient is requesting or refusing. Lastly, it was designed to be an 
actionable and a transferable medical order, rather than a legal document. That is, the patient’s 
care preferences documented on POLST becomes a set of medical orders [actionable] and it 




In Oregon, where POLST was developed, forms are electronically secured onto an e-
registry unless patient chooses to opt out. In theory, in emergencies, any health care providers 
(including first responders at the scene) can access the e-registry and identify patient’s EoL care 
wishes. Considering a complex and unpredictable illness trajectory at EoL, and a high utilization 
of emergency services among patients near death, state-wide implementation of the e-registry 
strengthened the way clinicians identify and honor dying patients’ written EoL care wishes. 
As of July 2018, 46 U.S. states and District of Columbia have developed state-specific 
POLST programs or are currently in the process of program development.16 Moreover, research 
evidence showing positive impacts of POLST use (decreased care transfer at EoL and prevention 
of unnecessary medical interventions) continued to accumulate. 147-150  
Authors of a published review of the POLST program examined 7 states (i.e., Oregon, 
Wisconsin, New York, California, North Carolina, Washington and West Virginia) and 
identified impact of POLST use in hospitals, hospices and nursing homes. The authors found that 
the POLST is a widely used care planning tool, receiving increased attention in clinical care 
settings. The authors also emphasized the need to evaluate the concordance between care 
preferences documented on POLST forms and treatments given to dying patients.110  
In EoL care delivery, where patient-centered care is a priority, examining concordant rate 
between care requested and intervention delivered is an integral part in understanding and 
planning high quality EoL care. However, published evidence on the concordance in POLST 
documentation and EoL care delivery has not been synthesized in a systematic review. The 
objective of this review is to examine the published evidence on the congruency between EoL 






This systematic review followed the guideline of Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA).151 Articles were eligible for inclusion if the authors 
examined the congruency between documented care wishes on a POLST form and subsequent 
care delivered to the patient. Other eligibility criteria also included studies that were written in 
the English, conducted in U.S., used quantitative methods, and published in a peer reviewed 
journal. Studies were excluded if the authors examined: the patient and/or family satisfaction on 
POLST form use and/or care delivered; the health care providers’ perspectives on the ease of 
POLST use; the legal or ethical issues surrounding advance directives; the effects of advanced 
care planning tools other than POLST (i.e., living wills, advance directives); or, the quality of 
POLST form completion, editorials and qualitative studies were also excluded.  
Information Sources 
The search for literature was conducted using four electronic databases: PubMed, 
Cochrane Library, Embase, and Cumulative Index of Nursing and Allied Health Literature 
(CINAHL). A manual search of the reference lists to screen additional articles for eligibility was 
also conducted.  
Search 
The search was conducted in the Spring of 2018, after a consult with a library 
informationist. A comprehensive search methodology was developed, using free-text words and 
Medical Subject Headings (MeSH). Search terms included the following keywords: “Physician 
Orders for Life-Sustaining Treatment”, “POLST”, “MOLST”, “Advance Directive 
Adherence/Utilization”, “Advance Care Planning”, “Treatment Adherence and Compliance”, 
“End of Life Care Planning”, “Consistency”, “Congruence” and “Concordance”. Searches were 




home, nursing home, acute care facility, or hospice). This was to allow a comprehensive 
screening of articles that may meet our eligibility criteria.  
Study selection 
After removing duplicate articles, titles and abstracts were screened to identify those that 
were relevant to the aim of this review. When the article was deemed relevant, full text was 
obtained for further screening applying the inclusion and exclusion criteria.    
Data collection process 
A standardized data abstraction tool was developed, which included the following 
information about the manuscript demographics: title, first author, and year published. Data 
audited on the study itself included: research design, region, setting, sample size, population of 
interest, and POLST section(s) examined for congruency (i.e., Cardiopulmonary Resuscitation 
(CPR), hospital transfer/ Intensive Care Unit (ICU) admission, preferred care setting / location of 
death, antibiotics, feeding and IV fluids and overall congruency). An evidence base table was 
developed to present the study characteristics and findings. 
To assess bias and quality of studies, we used the Newcastle-Ottawa Assessment Scale 
(NOS). The NOS is a validated quality assessment tool that is widely used for assessing quality 
of observational studies.152-154 The NOS examines three domains of a study quality: selection (4 
items), comparability (1 item), and outcome (3 items). When the highest criteria are met, 1 star 
per numbered item is awarded for both the selection and outcome domains. For the compatibility 
domain, the maximum number of stars awarded is 2, with the maximum possible stars awarded 
per study being 9. The NOS scores were converted into a trichotomous measure using the 
Agency for Health Research and Quality guidelines as follows: Good quality includes 3 or 4 
stars in the selection domain, 1 or 2 stars in the comparability domain and 2 or 3 stars in the  




comparability domain and 2 or 3 stars in the outcome domain; Poor quality includes 0 or 1 star in 
the selection domain or 0 stars in the comparability domain or 0 or 1 stars in the outcome 
domain.155 Two researchers (AT and JS) independently assessed each eligible article, and then 
met to discuss findings. A senior researcher (PS) was consulted to resolve any discrepancies. 
Results 
Figure 2 shows a PRISMA study flow diagram. In total, we identified 605 articles. After 
removal of 15 duplicates, 590 articles were screened for eligibility. Sixty-four articles were 
deemed relevant and proceeded to full-text review. After applying the predetermined inclusion 
and exclusion criteria 56 articles were excluded leaving 8 studies.  
Overview of Included Studies 
Table 1 summarizes the eight research studies audited. Five studies were conducted in 
Oregon, one study in Wisconsin, and two studies included two or more states. Care settings were 
varied: 4 studies were conducted in community settings, 3 studies in nursing homes, and 1 in a 
hospice setting. Six retrospective cohort studies and 2 cross sectional studies were included. 
Studies were published between the years of 1998 and 2014. Chart review was the most 
frequently used research methods (n = 7) while one study included chart review and in-person 
interviews.79  
The combined study sample size was 19,504 patients who completed POLST 
documentation with the majority coming from 1 study having over 17,000 patients. The majority 
of studies (n = 7) examined whether performing or not performing CPR was congruent with 
patient’s written wishes indicated.72,156-161 Two studies had CPR congruence as the only outcome 
of interest, while 5 studies also examined other outcomes: hospital transfer (n = 1), antibiotics 




hospital transfer, antibiotics (n = 1).72,156-158,160 Two studies also examined an overall congruence 
by totaling the rate of congruence obtained from different sections.142,144  
Study Findings 
Cardiopulmonary Resuscitation 
In 4 of the 7 studies, in which researchers examined documented Do-Not-Resuscitate 
orders, none of the patients from a hospice or nursing homes received unwanted CPR.72,157,158,160 
Three studies showed varying degrees of congruence. In one nursing home study with 54 
patients whom indicated their CPR preferences, researchers found that the provision of CPR was 
congruent in 49 cases (90.7%); incongruent cases (n = 5) were due to three patients who received 
CPR against POLST documentation, and for 2 patients whom did not received CPR although 
POLST documentation indicated that they wished to receive it.156 Two studies examined the rate 
of congruence in CPR among patients residing at home, for whom emergency medical service 
calls were made.159,161 In one study, 4 of 7 patients (57%) received CPR that was congruent with 
POLST documentation.159 Of remaining 3 cases, 1 patient (14.2%) was dead at the scene, 
receiving no medical interventions, and 2 (28.6%) received CPR until emergency personnel was 
able to retrieve data by calling an e-registry hotline. In the other study, CPR was congruent with 
patient wishes in 27 cases (84%).161 Researchers noted that no patients with a documented 
preference for CPR had resuscitation efforts erroneously stopped by emergency service 
personnel. 
Hospital Transfer / Intensive Care Unit (ICU) Admission 
Tolle and colleagues prospectively followed 180 nursing home residents who opted for 
hospital transfer only when comfort measures failed.72 After a year, 24 residents (13.3%) 
experienced hospitalizations. Rationales for hospital transfers were congruent with EoL care 




transfers were to extend life, rather than for comfort enhancement. Of those who were admitted 
to ICU setting, or received any treatments provided in ICU settings (e.g., intubation). 
Other researchers compared 157 forms obtained to medical records from the last 30 days 
of life. All documentation indicated that the hospital transfers made for patients were only for 
comfort purposes. Of 15 total hospitalizations identified, the majority of hospital transfers (13 
out of 15, 86.7%) were to control pain or sufferings.  
Preferred Care Settings / Location of Death  
Patient’s documented preferred care setting (e.g., current residence or hospital/ ICU) 
were compared with the actual location of death in one study.162 Most (n = 11,836) patients’ 
written wishes were to remain in their current settings, unless their pain and sufferings could not 
be controlled. Some (n = 4,787) indicated wishes to be transferred to hospital for medical 
treatments at EoL, but avoid ICU admission or stays, and 1,153 patients requested transfers to 
hospital including ICU settings to receive life-prolonging medical interventions. Of those 
patients who wished to remain in their current settings, 758 patients (6.4%) died in hospitals or 
emergency rooms. The majority (n = 10,464, 88.4%) patients died in their own residence or at 
out-of-hospital settings, representing a high congruence between preferred care setting, and the 
location of death. Of those who wished to be transferred to hospitals, but avoid ICU stays, 1,073 
(22.4%) deaths occurred in hospital settings. Nearly half of patients (44.2%) who indicated their 
wishes to be transferred to hospitals, including ICU, for any medical interventions had the 
hospital setting listed as their place of death.  
Antibiotics 
Congruency between antibiotics use at EoL and POLST documentation were examined in 
three studies.156,158,160 Hickman and colleagues examined 709 POLST documents, which 




antibiotics,158 9 patients (32.1%) received antibiotics treatments against their written wishes. 
Two discordant cases (22.2%) occurred when a family member revoked the original POLST 
order; rationales were not provided in the remaining 7 cases (77.8%). Of the 227 POLST forms 
with limited antibiotics preference indicated (i.e., patient wishes to receive antibiotics only for 
symptom relief), 60 patients met treatment criteria. Fifty patients (83.3%) received congruent 
care, where antibiotics were administered to enhance their comfort.   
In another study,160 researchers examined 52 forms from patients who opted to receive 
antibiotics. Thirty patients met treatment criteria (i.e. developed infections at EoL), and all 
received congruent interventions. A high rate of congruency between the use of antibiotics and 
documentation was also evident in another study.156 When researchers identified total 28 forms 
with documented preferences for antibiotics use, 24 patients (85.7%) received antibiotics.  
Feeding and Intravenous (IV) fluids 
When preferences for feeding tube were compared with medical charts from the last 2 
weeks of life, researchers found that the feeding tubes were implemented in 32 patients 
(94.4%).156 In one discordant case, the patient (2.9%) received a feeding tube when it was not 
indicated; another discordant (2.9%) case involved an incident where the patient opted for 
feeding tube, but did not receive one. In the same study, researchers also examined 38 POLST 
forms which had preferences written for the use of IV fluids at EoL. IV fluids were administered 
in 32 cases (84%).  
Other researchers examined 678 forms of deceased nursing home residents.158 Most (n = 
417, 61.5%) indicated wishes to not receive feeding tube at EoL. Chart review revealed that 
almost all (n = 416, 99.8%) received concordant care. Of the 193 deceased nursing home 
residents who requested to receive feeding tube at EoL, but only for defined trial period, the 




indicating a long-term usage. Furthermore, 4 of these patients (80%) died with the feeding tube 
in place.  
When Hammes and colleagues reviewed 268 POLST documentation from one 
community setting,160 only 4 POLST forms indicated long-term feeding tube use. Two 
participants (50%) did not meet treatment indications (i.e., needing tube feeding to meet caloric 
requirements to sustain life) and another two (50%) received feeding tube at EoL. 
Overall Congruency 
After examining different POLST sections (i.e., CPR section, antibiotics section) and 
congruence with each care delivered per section requested, researchers in three studies further 
computed an overall congruency between documentation and all applicable medical 
interventions withheld/ provided.156-158 In one study, the researchers initially found 52 potential 
discordant cases (20.4%) from 255 POLST documentation and medical chart reviews.157 
However, further review of these discordant cases revealed two important factors. First, most 
discordant cases involved family member or surrogate’s request to withhold medical 
interventions (e.g., CPR). And such decisions to override patient’s POLST wishes were most 
often occurred after they were informed by medical providers that the patient would not likely to 
survive even if treatment [requested on POLST form] were delivered.157 By conducting further 
review of discordant cases, researchers were able to conclude that only 2 out of 255 cases (4%) 
showed incongruent care. 
The overall congruence reported in another study was significantly lower.156 After 
comparing types of EoL care interventions delivered to the patient with the corresponding 
sections of total 54 POLST forms (i.e., CPR, transfer, antibiotics, artificially administered 
nutrition and artificially administer fluids section) only 21 cases (39%) showed that all written 




POLST sections were congruent with actual care delivered at EoL. Three cases (5.6%) were 
congruent in fewer than half of POLST sections examined, whereas two cases (3.7%) showed 
discordant care in all POLST sections examined.  
Quality of included articles 
Table 3 provides a summary of the methodological quality assessment of all included 
studies. The quality scores ranged from minimum 7 stars to maximum of 9, with half of the 
included studies scoring 8 stars. All included studies scored the highest possible in outcomes 
domain, that is 3 stars. All studies clearly stated means of outcome assessment, length of follow 
up, and adequate rate (i.e., 80% or higher) of participants followed up. Five studies (62.5%) had 
2 stars awarded in comparability domain, which assesses whether study participants were 
controlled for cofounders. Three studies did not control study groups for potential confounding 
factors other than age, sex or marital status. Lowest scores were found in the selection domain. 
Only three studies (37.5%) scored 4 stars while rest scored 3. Although all included studies had 
representative study sample, there were no description or inclusion of non-exposed cohort (that 
is, those who did not have POLST forms) in 5 studies. 
Discussion  
To the best of our knowledge, this is the first systematic review that examined the 
congruence between POLST documentation and subsequent medical care delivered to patients at 
EoL. Our review synthesizes the evidence on the congruence rate between 1) specific POLST 
section and care delivered, as well as 2) overall congruence of POLST documentation and EoL 
care received.  
Most of the included studies were retrospective cohort studies that were conducted in 




cardiac arrest and the actual delivery of or withheld of resuscitation efforts was the most 
commonly studied intervention. It is also where the highest congruence rates were observed.  
There were several incongruent cases noted in the delivery of EoL care interventions, 
namely, hospital transfer, antibiotics use, and feeding tube use. Most commonly reported reason 
for unwanted hospital transfers, or the use of antibiotics among dying patients were new onset of 
infections. Previous studies on the health status of nursing home residents revealed that 
infections are, in fact, the most commonly encountered health problems among elderly 
population.163-165 Also, it is one of the most common factors that causes unplanned changes in 
one’s EoL care processes.166 Combined with the fact that not all nursing homes are adequately 
equipped to provide screening of, or management of infections that are prevalent in EoL, it 
appears to be a challenging task to bring immediate changes, or measurable outcomes in this 
aspect of EoL care.167 However, continued efforts in infection surveillance, antibiotic 
stewardship and in-depth understanding of resident’s EoL care goals are one of few strategies 
that can be implemented to minimize over-utilization of potentially harmful treatments.  
Overall congruence between preferred use of feeding tube and actual care delivered 
revealed another area that needs improvement. Researchers pointed that incongruent cases in 
feeding tube use were most commonly seen among those who opted to have feeding tubes only 
defined trial period. Some patients had feeding tube in place for longer than 30 days, raising 
concern for what constitutes as a trial period, and some even died with feeding tube in place. 
Researchers called for the need for clarification of the term defined trial period as it has never 
been defined by the National POLST Program Task Force (NPPTF) organization. Although it is 
difficult to conclude that incongruent cases in feeding tube use were solely due to lack of 




forms, especially in advance care planning document, should avoid any terms that can be 
misinterpreted or misunderstood.168  
One of notable study findings was the evidence of high congruence for a preferred route 
of medication administration. Among those who expressed EoL care preferences to receive 
antibiotics, but only via oral routes, all (100%) study participants received care that was 
congruent with their written wishes. This signifies a high specificity that can be achieved through 
POLST forms. This finding resonates with previous research work, which noted an effectiveness 
of POLST forms in guiding EoL care.17  Meier and Beresford explained that POLST provides a 
quick and clear guidance in EoL care, through highly specific care preference documentation for 
common interventions used in EoL journey.17 When examining concordance between POLST 
documentation and subsequent care delivered to patients, it is important to understand that some 
discordant cases may arise from issues that are related to POLST form itself (structural issues) or 
differences in familiarity of POLST program among general population. While POLST is 
gaining increase attention across the nation, NPPTF allows each U.S. state to develop a state-
specific POLST program and operate it independently.168,169 This, in turn, leaves a room for 
inherent differences to arise in type of EoL care addressed and the option one can choose from. 
For example, Wisconsin POLST form offers four different options under tube feeding 
preferences (i.e., no feeding tube, defining period usage, long-term use or determine the use 
when needed) while West Virginia only offers two (i.e., no feeding tube, or long-term feeding 
tube use).  
Type of EoL care option captured on state forms also differ significantly. For example, 
antibiotics options are no longer being assessed through POLST form in the state of Oregon. In 




section from its POLST form, after nearly 20 years after POLST program was developed.170 
Such decision was due to a new research findings. That is, Hickman and colleagues found that 
antibiotics section on POLST forms had little impact on the actual usage of antibiotics between 
two groups (patients who opted for antibiotics at EoL and patients who opted for no antibiotics at 
EoL). In this retrospective cohort study, the actual use of antibiotics at EoL were similar between 
two groups, regardless of written wishes indicated on antibiotics section; 32.1% and 30.4% 
respectively.158 In addition, lack of research evidence that antibiotics use at EoL enhances 
survival outcomes or comfort for those who are near death supported Oregon’s decision to 
remove antibiotics use section in its entirety.  
Each state participating in POLST program has different levels of program designation, 
classified as maturity status. From lowest to highest status, a state POLST program can move 
from developing, endorsed, and mature status when it meets certain milestones or key criteria 
that NPPTF requires.16,171 When the program first begins a state-wide dissemination of POLST, 
it obtains a developing status and then move toward endorsed when the state consensus is met for 
a single POLST form for a state-wide, and then to mature status when POLST becomes a part of 
standard of care for elderly and frail patients and is used as an advance care planning tool in 
more than half of all medical facilities (e.g., nursing homes, hospitals, hospice care settings) 
within its state.171 Depending on the maturity status of the POLST program, public awareness on 
POLST program itself, and how it can be utilized to tailor one’s EoL care may vary significantly. 
For example, in an area where POLST program is used in the majority of healthcare settings, 
medical providers may be more familiar with the fact that POLST forms should be re-visited 
when patient status improves or declines further, and patients be given many opportunities to 




of public or provider awareness and competency on how POLST can be utilized to tailor one’s 
EoL care remains unstudied, which could explain discordant cases observed in included studies.  
Making EoL care decision is a challenging process. It can also be emotionally draining 
for those who are faced with or involved in decision processes. A well-informed advance care 
planning requires a utilization of a guiding tool that facilitates care discussions, while presenting 
treatment options that are relevant to EoL care. It should also be systematically monitored for 
continued quality improvement and be closely examined for outcomes it brings to its target 
population. This systematic review synthesized published evidence on the congruence between 
POLST documentation and subsequent care delivered at EoL, and provided comprehensive 
resource for healthcare providers, health science researchers or policy makers who are seeking 
scientific evidence on POLST use and impact it brings. It is clear that gathering additional 
scientific evidence on the use of POLST across different care settings or regions will help 
advance future EoL care practices.  
Limitations 
There are number of limitations that are worth mentioning. First, although we developed 
search strategy with the help of library informationist, it is possible that our search strategy may 
have not identified all relevant research articles on this topic. Second, while we limited our 
inclusion criteria to research articles published on peer reviewed journals, potentially important 
and relevant findings that addressed our research question could have been existed in grey 
literatures, and/or unpublished articles. That is, publication bias may be present with studies not 
finding concordance not being published. Third, we found that several authors on included 
research articles had affiliations with NPPTF; some served their roles as consultants or board 
members. In addition, one of authors in the included study appeared as co-author in two other 




Another significant limitation of this systematic review is that five of included studies 
were conducted in the state of Oregon, and two other multi-state studies included Oregon as one 
of their geographic study locations. Although this could be considered as a limitation, POLST 
was first developed, introduced, and disseminated in Oregon. Needless to say, as a birthplace of 
POLST program itself, the most number of resources and data are available from Oregon. 
Conclusion 
Based on our findings, it is clear that POLST is an effective advance care planning tool 
that can be used to discuss, document, and to deliver EoL care that reflects patient’s care 
preferences. Provision of resuscitation at the time of cardiac arrest or time of death was 
universally respected, while there were mixed results in the use of feeding tube or IV fluids use 
at EoL.  
Additional research is recommended to identify congruence between documented care 
wishes and actual care delivered among patients who experienced multiple care transitions or 
have moved across state near the time of death. Further studies should also compare congruence 
between POLST documentation and care delivered between groups of patients who may suffer 
from different medical conditions. Empirical studies are needed to ascertain the 
comprehensiveness of POLST items in capturing relevant and important EoL care interventions. 
There is a need to conduct prospective observational studies within various patient care settings, 






















































had a POLST 
recording DNR 
designation, 
and opted for a 
transfer only if 
comfort 
measures failed 
None of study participants received unwanted CPR. Among 26 participants 
(13%) who were hospitalized during the study period, no one received ICU 
care, or ventilator support. In 85% of hospitalizations, patients were 
transferred because the nursing home could not control suffering; in four 
cases (15% of hospitalizations), the transfer was to extend life. None of 
hospitalized participants received CPR in the hospital, and orders to focus on 














died in year 
1997, and had 
POLST forms 
Overall, 21 participants (39%) had POLST instructions followed in all 
applicable categories of care. 28 participants (51%) received care that 
matched POLST at least half of categories of care. For 3 participants, care 
consistent was fewer than half of relevant categories. For 2 participants, care 
provided was not compliant with POLST. CPR category was consistent with 
POLST instructions in 49 cases (91%). The medical treatment that subjects 
received was at the level of medical intervention ordered in 25 cases (46%), 
at less invasive level in 18 cases (33%) and at a more invasive level in 11 
cases (20%). Among those who opted to receive artificially administered 
nutrition and IV fluids had their wishes honored 94% of the time. Antibiotic 
administration was in concordance with POLST documentation 86%. 
Hickma














Hospice 256 Residents with POLST forms 
Preferences for treatment limitations were respected in 98% of cases and no 
one received unwanted CPR, intubation, ICU, or feeding tubes. Eight (3%) 
treatment deviations identified of 255 subjects. 3 patients received less 
aggressive treatment, 5 received overtreatment. 
Hickma














had a POLST 
form 
Of 299 deceased residents with DNR order, none received unwanted CPR, 
100% of residents received treatment consistent with their orders. 
74.3% (26/35) of treatment provided to residents with orders for “comfort 
only” were consistent with the goal of enhancing comfort. 98.3% of treatment 
provided were consistent with the “limited additional” intervention order. The 
overall consistency rate between treatment provided and orders about medical 
intervention was 91.1% 







92.9%. For feeding tube preference and use, consistency rate was 63.6%. 
Overall consistency between all treatments provided and POLST orders was 
94% 
Schmid













whom the calls 
were made 
Chart review revealed there were two subjects who received CPR and 
medical interventions until the POLST forms were identified through POLST 
registry, after which they were terminated to follow POLST orders for DNR. 
Three cases matched the recorded wishes and one subject requested a 
transport, overriding POLST form. During patient/surrogate interview, 10 out 
of 11 (91%) of interviewees believed that written POLST care wishes of the 
patients were honored. 
Hamme









/ Chart, Death 
Certificates 
review 
WI Community 255 
Residents who 
died between 
Sept 2007 – 
March 2008, 
and had a 
POLST form 
None of the 255 decedents with a dated POLST form were resuscitated in the 
last 30 days of life. 5 decedents who opted to receive full treatment option 
had hospitalization, ICU stay and intubation. None of 157 decedents who 
documented Comfort-care only under Section B. were intubated or received 
care in ICU setting. 
Of the 4 decedents who had orders for long-term feeding tube use, two 
received feeding tubes; the other did not because the treatment was not 
indicated. 
Antibiotic use was consistent with POLST orders; 20 decedents received 
antibiotic treatments to enhance comfort, and 10 decedents with no IV/IM 
antibiotics received antibiotics which were administered orally. 
Fromm












OR Community 17,902 
Residents who 
died of natural 
causes from 
2010-2011, had 
a POLST form 
Striking difference in proportion of in-hospital death that was consistent with 
POLST orders. Of all subjects with POLST, only 6.4% with Comfort-only 
care (hospital transfer only to enhance comfort, with no ICU care) died in the 
hospital compared with 44.2% of those with orders for full treatment (transfer 
to hospital or ICU), and 34.2% for those with no POLST form. Overall, 








who had a 
POLST form 
Of 50 subjects with DNR order, 11 subjects (22%) had resuscitation 
attempted by EMS personnel. By hospital admission, resuscitation efforts had 
been ceased or not attempted for 94%. Of 32 patients with a POLST form 
specifying attempt resuscitation, 27 (84%) had resuscitation attempted. 
Overall, concordance rate of patients with DNR orders having resuscitation 
efforts stopped before hospital admission was 94%. 
CPR: cardiopulmonary resuscitation; DNR : do not resuscitate; ICU: intensive care unit; IV: intravenous; MIS: medical intervention section (i.e. comfort only, limited treatment, 












Tolle, et al., 
1998 
 
Lee, et al., 
2000 
 




































Selection of the non-exposed   *    * * 
Ascertainment of exposure 
 















































Outcome          
 








































































Overall quality Good Fair Good Good Fair Good Good Good 
 
“ * ” : meet NOS threshold 
Note : Good quality: 3 or 4 stars (*) in selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome domain; Fair quality: 2 stars in 
selection domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome / exposure domain; Poor quality: 0 or 1 star in selection domain OR 0 




Chapter 3: Variations in Physician Order for Life-Sustaining Treatment (POLST) program  






The following chapter is an environmental scan conducted to examine current status of POLST 
maturity status across the nation, and to examine similarities and differences in incorporation of 
infection, and symptom management options address on all available POLST forms. 
 
Note: This manuscript has been published on Journal of Palliative Medicine   
Tark A, Agarwal M, Dick AW, Stone PW. Variations in Physician Orders for Life-Sustaining 
Treatment Program across the Nation: Environmental Scan. J Palliat Med 2019. Doi: 
10.1089/jpm.2018.0626. 









Physician Orders for Life-Sustaining Treatments (POLST) is an advance care planning tool that 
designed to document End-of-Life (EoL) care wishes of those living with limited life 
expectancies. Although positive impacts of POLST program has been studies, variations in state-
specific POLST programs across the nation remains unknown.   
 
Objective  
Identify state variations in POLST forms and to determine if variations are associated with 






Using national POLST website, state-specific POLST program characteristics were examined. 
With available sample POLST forms, EoL care options were abstracted. 
 
Results  
Of all 51 states (50 U.S. states and Washington, D.C examined), the majority (n=48, 98 %) were 
actively participating in POLST; 3 states (5.9%) had Mature status, 19 states and District of 
Columbia (39.2%) were Endorsed, 24 states Developing (47.1%), and 4 states (7.8%) non-
Conforming. Forty-five states (88.2%) had forms available for review. Antibiotics and 
intravenous fluids options were identified in 32 (71.1%), and 33 (73.3%) POLST forms 
respectably. Hospital transfer and use of oxygen were mentioned in all forms. Use of respiratory 
devices (i.e., CPAP and BiPAP) were mentioned on 27 (60%) forms while ventilator or 
intubation use were mentioned in 36 POLST forms (80%). No associations were found between 
POLST maturity status and provision of treatment options.  
 
Conclusions 
Variations in integration of infection and symptom management options were identified. Further 
research is needed to determine if there are regional factors associated with provision of 







Advances in medical technologies, combined with an aging population, have resulted in 
an increased number of individuals living with complex health issues. Previous researchers 
found that the number of elderly Americans suffering from chronic illnesses and comorbidities 
has increased drastically.9,172 65 Many of these people are at the end-of-life (EoL) and at risk for 
infection, which is often terminal but results in burdensome hospitalizations.15,121 Despite wishes 
to remain at home and avoid aggressive treatments, many individuals die in acute care settings, 
including emergency rooms or intensive care units.117,120,173 Delivering care that reflects 
individual’s values is a priority of care at EoL.  
Discussions eliciting patients’ preferences for interventions at EoL are difficult. As many 
as 70% of individuals at the EoL lack the capacity to communicate their preferences due to the 
progressive and advanced nature of their illnesses (e.g., dementia or stroke).174 Advance care 
planning, a process of documenting individual’s preferences for medical care, is one way to 
understand individual’s preferences in the face of incapacity. In U.S., Living wills are the most 
widely used advance care planning tool.175 Since the passing of the Patient Self-Determination 
Act in 1990, which promoted the use of advance directives, public awareness on advance 
directives has increased; however, this has not translated into an increased proportion of 
individuals who actually complete advance directives.176 Although it has been nearly 6 decades 
since advance directives were first introduced, the proportion of individuals completing advance 
directives remains low (i.e., less than 30% completion rate), and EoL care remains 
suboptimal.45,177,178 
Recognizing shortcomings of conventional advance directives, and to fulfil the need for 
an alternative tool that can help honor a patient’s EoL care wishes, a group of medical ethicists 
 43 
 
from Oregon formulated a new advance care planning tool called the Medical Treatment 
Coversheet in 1991.69 After validating the instrument and successfully completing pilot studies, 
it was renamed “Physicians Orders for Life-Sustaining Treatments (POLST)” and was released 
for use in Oregon in 1995. Similar instruments have been developed in other states, but there are 
some differences. 
Although POLST and advance directives share similar aims, which are to document 
individual’s EoL care wishes, they differ in important ways. Advance directives are designed for 
any adult age 18 years or older; POLST targets people who are suffering from advanced, 
progressive, illnesses and/or frailty, and living with limited life expectancy.54,62 By targeting 
intended users with advanced illness and who are close to death, POLST offers the opportunity 
for dying patients to articulate their care preferences with the knowledge of their on-going 
medical conditions. In addition, medical interventions documented on POLST forms become a 
set of portable medical orders upon completion, which increase the likelihood that the patient’s 
preferred treatment options will be honored across care settings.158 The POLST paradigm was 
designed not only to preserve the autonomy of terminally ill individuals, but also to facilitate 
much needed EoL conversations between a dying patient and treating medical providers.  
While the effectiveness of the POLST program and the positive impact it has had on EoL 
care is well-documented in previous studies, implementation of the POLST program has been 
driven by states, resulting in state-level variation in POLST content, timing, and rates of 
adoption, the consequences of which have not been addressed adequately.179-181 Currently, the 
National POLST paradigm Task Force (NPPTF) supports implement and operation of state 
POLST programs, requiring only that the general tenets of POLST Form Usage Policy be 
followed (i.e., POLST must be a voluntary tool and be used within the intended population), 
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which has resulted in wide variation in POLST design and content across the country, 169,182,183 
including EoL treatment options that are discussed and care preferences documented. A close 
examination of this variation is an important step in identifying best practices in POLST 
programs. 
The NPPTF monitors and designates the “maturity” of state-specific POLST programs 
using 4 categories, each representing different stages of program development and 
implementation (see http://polst.org/programs-in-your-state/).171  
Developing status indicates that the state coalitions have contacted NPPTF to develop a 
state-specific POLST program and are currently working toward the goal of implementing 
statewide POLST program. States with developing status can be at any stage of program 
development activities, ranging from a designing phase of POLST forms, to on-going regional 
pilot studies with POLST program.  
Endorsed status is for the states where POLST programs have been implemented, and 
have met key criteria (i.e., presence of a single POLST form per state). Different issues relevant 
to the state-level POLST program (i.e., legal, regulatory, education, and quality improvement) 
must also be addressed.  
Mature status is the highest level of POLST recognition. It is reserved for states where 
the POLST programs have been endorsed as a part of the standard of care. Mature status is 
obtained after NPPTF confirms that the POLST program is being used in more than 50% of all 
medical facilities (i.e., hospitals, nursing homes, and hospices). 
Lastly, for POLST programs that are already developed, but failed to comply with 
requirements in either structural component of POLST forms, or how the programs are being 
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implemented within a state (e.g., voluntary), non-conforming status is assigned. This status 
indicates that the state’s POLST program is not on a pathway to be endorsed by NPPTF.  
The purposes of this research study were to: 1) identify state variations in how EoL 
treatment options were captured on POLST forms through environmental scan, and 2) determine 
if variation in EoL treatment options on the POLST forms was associated with the maturity 
status of the program. Environmental scan is a research method widely used in assessment of 
both internal and external environment of an organization, organizational practices, or health 
programs. It produces important insights on current trends and occurrences based on exciting 
resources and can assist with the development of evidence-based policies in future practices. 
Methods 
 
An environmental scan was conducted using the national POLST website 
(www.polst.org), states’ Department of Health websites and by searching the internet to identify 
the most up-to-date information on POLST programs in all 50 U.S. states and the District of 
Columbia (hereby referred to as states). Data collection occurred between August 2017 and 
February 2018. When available, sample POLST forms were obtained using state POLST 
websites and/or by searching the World Wide Web.  
A standardized data collection tool was developed (available upon request) after 
reviewing the national POLST website, published research articles describing the POLST 
program, and consultations with experts.110 The following data were obtained: a) name of each 
state POLST program; b) POLST program maturity status; c) year POLST program began; d) 
year POLST program was endorsed or distinguished as mature (when applicable), and e) 
availability of a sample POLST form (Y/N). When the POLST program had a non-conforming 
maturity status, we further identified the reason (i.e., specific tenet it violated).  
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When a POLST form was available, we examined how EoL treatment management 
options were captured including: antibiotics use, intravenous (IV) fluids, hospital transfer, 
medication administration by any route, oxygen use, utilization of less-invasive respiratory 
devices (i.e., Bi-level Positive Airway Pressure (BiPAP) or Continuous Positive Airway Pressure 
(CPAP)) and invasive respiratory devices (i.e., ventilation/ intubation). Because aforementioned 
treatment options can be found in multiple different places in a POLST form (i.e., under Comfort 
Measures, Limited Treatment and Full Treatment and/or under a separate assessment section), 
for each treatment option we assessed a) the frequency the treatment option listed, and b) the 
location(s) where the treatment options were found on the form.   
A double data collection process was performed; for every 5 states in which data were 
collected by the first data collector (AT), a second data collector (MA) randomly selected one 
state and independently extracted data. During the data collection period, all authors met weekly 
to discuss findings, review data collection progress and to clarify any discrepancies. Inter-rater 
agreement was calculated using the kappa statistic. Distributions and descriptive statistics were 
computed, and chi square tests were used to test for associations between POLST maturity status 
and treatment options.  
Results 
 
Data were collected from all 51 state POLST programs (i.e., 50 states and Washington, 
D.C.). The inter-rater agreement was excellent (Kappa = 0.77).184  
Table 3 presents the characteristics of the programs. The distribution of state POLST 
program start years is presented in Figure 3. The first program began in 1991 (Oregon) and the 
most recent began in 2017 (Arkansas). Excluding three states that did not specify the start year 
(i.e., Marylnd, South Dakota and Wyoming), half (n = 24) of all state programs began between 
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the years of 1991 to 2008, and the rest in the years of 2009 to 2017. The maximum number of 
state programs that began in the same year were 6 programs, which occurred in year 2010, 
followed by 5 programs in year 2012.  
Three states (i.e., California, Oregon and West Virginia, 5.88%) had mature status, 20 
states (39.22%) were endorsed, 24 states (47.06%) were developing, and 4 states (7.84%) were 
non-conforming. Reasons for non-conforming included: missing a core elements (Massachusetts, 
Vermont), omitting limited-intervention section on the form (Nebraska) and mandating 
completion to certain patient population (Maryland).  
The year that state’s program obtained its endorsed status was identifiable for 23 states. 
Between years of 2004 and 2017, a total 20 states obtained, and maintained their endorsed status, 
while 3 states went on to obtain a higher (i.e., mature) status. An average time it took for a state 
program from the start year to the receipt of endorsed status was 6 years (SD = 4.09, median = 
5). New Hamphire’s POLST program took the longest time to transition from start to endorsed 
status, total 14 years, while Hawaii’s POLST program took less than a year to move from start to 
endorsed status.  
Of the three states that went on to obtain mature status, both Oregon and West Virginia’s 
programs obtained mature status in 2013. Oregon maintained endorsed status for 13 years before 
it obtained mature status, and West Virginia maintained endorsed status for 3 years. California 
obtained mature status in 2016, after having endorsed status for 9 years. In average, it took 8 
years (SD = 1) for a state POLST program to transition from endorsed to mature status; 
maximum 9 years, and minimum 7. An average of 14 years were lapsed between the year it 
started, and the year mature status was obtained.  
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There were several different names used. The majority (n = 18, 35.29%) used the name 
POLST, followed by POST (Physician Orders for Scope of Treatments) in 8 states (15.69%). 
Seven states (13.73%) used the name MOLST and 6 states (11.76%) used MOST with the “M” 
standing for Medical. Two programs (3.92%) were called TPOPP (Transportable Physician 
Orders for Patient Preferences) and another 9 states (17.65%) used state-specific names (e.g., 
AzMOST for Arizona, DMOST for Delaware, OkPOLST for Oklahoma, WyoPOLST for 
Wyoming). The program name for one state (i.e., South Dakota, 1.96%) was not specified. 
Forty-five states had forms available for review. The 6 states that did not have a sample 
POLST forms were Alabama, Alaska, Nebraska, South Dakota, Wisconsin and Washington 
D.C,). All mature programs (n = 3) had a sample form available; 19 from endorsed programs, 20 
from developing, and 3 forms from non-conforming programs.  
Frequencies and specific locations for the EoL treatment options are presented in Table 
4. Patient preferences for antibioitc therapies were assessed on 32 forms (71.11%); 2 out of 3 
programs from mature status (66.67%), 14 out of 19 (73.68%) endorsed and developing, and 2 
out of 3 (66.67%) non-conforming status. Most forms assessed antiobiotic preferences only once 
(n = 28, 62.22%); and, it was most frequently listed under the full treatment section (n = 15, 
33.33%), followed by the comfort measures section (n = 13, 28.89%). There were 4 forms 
(8.89%) that contained antibiotics use under two different sections; these sections were comfort 
and limited section (n = 3) or limited and separate section (n = 1). 
Preferences for IV fluids use at EoL were assessed on 33 forms (73.33%), which included 
all forms from mature programs (n = 3, 100%), more than half of forms from endorsed (n = 13, 
68.42%) and developing status (n = 16, 80%) and 1 from non-conforming program. Similar to 
antibiotics use, preferences for IV fluids were mostly mentioned once per form (n = 28, 62.22%); 
 49 
 
however, it was listed under the limited treatment section. Five forms (11.11%) assessed IV 
fluids use option twice per form, all under a limited and full treatment section.  
Patient preferences for the hospital transfer at EoL were assessed in all forms (n = 45, 
100%). Three quarters of state forms (n = 34) captured transfer option three times; under all 
medical intervention sections (i.e., comfort, limited and full treatment). When this option was 
mentioned twice (n = 5, 11.11%), they were all under a comfort and limited treatment section. 
When mentioned once (n = 4, 8.89%), all were located under a separate section.  
All forms assessed patient preferences for medication administration by any route, as 
well as the options to receive oxygen for respiratory symptom relief. These preferences were all 
captured under the comfort measures section. All forms from mature and non-conforming status 
contained the option to use respiratory devices (i.e., BiPAP/CPAP and intubation/ventilation). 
Program maturity status was not related to the assessment of BiPAP/CPAP preferences, with this 
present 94.74 to 100% of the time. All forms that contained preferences for intubation and 
ventilation use (n = 41, 91.11%) mentioned this option only once and this weas mostly under full 
treamtent sections (80%), or under a separate section (11.11%). 
Because there was no variation in three treatment options (i.e., transfer to hospital, 
medication by any route, oxygen) associations between maturity status and treatments options 
could only be compared to antibiotics use, IV fluids use, BiPAP/ CPAP, intubation/ventilation 
use. We did not find any significant associations between treatments mentioned and POLST 
maturity status (data not shown). 
Discussion  
 
This is the first comprehensive examination of how POLST forms vary across the nation. 
Variations in types, interventions, locations, or frequencies of options captured on forms could 
 50 
 
be explained by the lack of consensus on specific EoL treatment care options that should be 
addressed. Maturity status of the program was not related to the variation in the forms. 
Previous researchers largely focused on the use in clinical care settings (i.e., nursing 
homes), or lessons learned from implementing a program in a single state.185-187 Recently, 
Hickman and Critser reported their findings on the national and state level variations in POLST 
programs.181 However, their study aimed to identify whether the state forms were adherent to the 
national standards by identifying inclusion of specific sections (e.g., medical order) and 
exclusion of language that ia prohibited by NPPTF. These investigators only examined the 
sample POLST forms from endorsed or mature programs, excluding information from 
developing or non-conforming POLST programs from their final analysis.181  
A large number of unnecessary and burdensome hospital transfers occur near EoL.188 
These transitions become a source of disconcordant care that increases both psychological and 
physical burdens for a dying patient. It is also closely related to the overutilization of aggressive 
treatments that may contradict a dying patient’s EoL care wishes.12,91 Many elderly individuals 
with advanced illness transferred to hospitals die within weeks of hospitalization.122,123,189 While 
conventional advance directives do not assess individual’s preference for hospitalization near 
death, all POLST forms we examined (n = 45, 100%) contained a hospital transfer option, at 
least once. Most forms contained hospital transfer under all three sections (i.e., comfort, limited 
and full treatment sections).  
Decision-making surrounding antibiotics use at EoL is difficult parts. Due to ethical 
concerns, examining outcomes (e.g., quality of life) among dying patients with or without 
antibiotics use is not feasible through randomized control trials. As a result, the evidence is based 
on retrospective cohort designs, with no comparison groups.190-193 Lack of guidelines, and the 
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absence of high-level scientific evidence on antibiotics use at EoL adds challenges to 
determining what is the best practice in the infection managements among elderly and frail 
individuals.96,194  
Oregon, the birthplace of POLST program, included an antibiotics option on its form 
since the first time POLST was introduced. However, nearly a decade after the program’s 
initiation, this section was remove after a review of research evidence found little difference in 
actual use of antibiotics regardless of  written preferences.158  
An aim of POLST is facilitate advance care planning that can enhance quality of life for 
those who are dying. By using a standardized national tool, one should be able to receive a care 
that is documented and desired, regardless of patient’s physical location (e.g., care institution 
located in a different state). Even if the care transfer was made near the time of death, across 
states, POLST documentation should always be easily identifiable and patient wishes be 
respected. The variations we observed make interstate transfer of POLST orders unlikely.  
Limitations 
This environemntal scan was limited to EoL treatment options that were relevant to 
infection and/or symptom management. Discussing treatment options outside infection/ symptom 
management (such as tube feedings) were out of scope of this study. While we attempted to be 
comprehensive and current, not all forms were available. Our findings represent a cross-sectional 
view, and it does not provide causality. The forms used during data collection may have been 
revised, and/ or maturity status changed. Although it may be useful to report summary of 
changes that were made to states’ POLST programs or forms since the completion of our data 




Oregon has recently separated from NPPTF, due to differences in views for receipt of 
industry funding. 44 Although the national POLST website indicated that Oregon’s POLST 
program was mature, this information has subsequently been removed.70,152,170  Nevertheless, we 
classified Oregon’s POLST program status as mature program throughout our data collection and 
analysis.  
Directions for the future research 
We highlighted a gap in knowledge in current status of POLST program implementation. 
Future research is recommended to identify how variations in EoL care options, particularly 
antibiotics preferences and other infection-related care options, addressed on advance care 
planning tools impact appropriate use of medication at EoL. Determining if EoL care wishes on 
POLST forms were honored for individuals who relocate to a different state, close to the time of 
death, is also needed.  
This study yielded information that can inform policy makers, researchers and clinicians. 
Close monitoring of POLST program for its futher improvements, and disseminating new 
research findings on areas that can be improved will facilitate further success of POLST 
program. In addition, it will provide a platform for increased public awareness on the importance 




























Reason for Non-Conforming status 
Alabama* Developing TOPP 2004 N/A N/A  
Alaska* Developing MOLST 2015 N/A N/A  
Arizona Developing AzMOST 2012 N/A N/A  
Arkansas Developing POLST 2017 N/A N/A  
California Mature POLST 2007 2009 2016  
Colorado Endorsed MOST 2005 2011 N/A  
Connecticut Developing MOLST 2012 N/A N/A  
Delaware Developing DMOST 2010 N/A N/A  
Florida Developing POLST 2003 N/A N/A  
Georgia Endorsed POLST 2012 2013 N/A  
Hawaii Endorsed POLST 2009 2009 N/A  
Idaho Endorsed POST 2007 2011 N/A  
Illinois Developing POLST 2010 N/A N/A  
Indiana Endorsed POST 2013 2017 N/A  
Iowa Endorsed IPOST 2006 2015 N/A  
Kansas Endorsed TPOPP 2008 2016 N/A  
Kentucky Developing MOST 2010 N/A N/A  
Louisiana Endorsed LaPOST 2011 2012 N/A  
Maine Endorsed POLST 2008 2015 N/A  
Maryland Non-Conforming MOLST N/S N/A N/A POLST form not voluntary 
Massachusetts Non-Conforming MOLST 2010 N/A N/A Lacking limited intervention section 
Michigan Developing POST 2011 N/A N/A  
Minnesota Developing POLST 2009 N/A N/A  
Mississippi Developing POST 2014 N/A N/A  
Missouri Endorsed TPOPP 2008 2016 N/A  
Montana Endorsed POLST 2010 2011 N/A  
Nebraska* Non-Conforming POLST 2005 N/A N/A Lacking core elements of POLST form 
Nevada Developing POLST 2009 N/A N/A  
New Hampshire Endorsed POLST 2003 2017 N/A  
New Jersey Developing POLST 2011 N/A N/A  
New Mexico Developing MOST 2012 N/A N/A  
New York Endorsed MOLST 2003 2006 N/A  
North Carolina Endorsed MOST 2004 2008 N/A  
North Dakota Developing POLST 2010 N/A N/A  
Ohio Developing MOLST 2006 N/A N/A  
Oklahoma Developing OkPOLST 2007 N/A N/A  


















Reason for Non-Conforming status 
Pennsylvania Endorsed PAPOLST 2000 2011 N/A  
Rhode Island Developing MOLST 2011 N/A N/A  
South Carolina Developing POST 2012 N/A N/A  
South Dakota* Developing N/S N/S N/A N/A  
Tennessee Endorsed POST 2005 2009 N/A  
Texas Developing MOST 2013 N/A N/A  
Utah Endorsed POLST 2002 2011 N/A  
Vermont Non-Conforming COLST 2005 N/A N/A Lacking core elements of POLST form 
Virginia Endorsed POST 2006 2016 N/A  
Washington Endorsed POLST 2000 2005 N/A  
West Virginia Mature POST 2002 2005 2013  
Wisconsin* Endorsed POLST 1997 2008 N/A  
Wyoming Developing WyoPOLST N/S N/A N/A  
Washington D.C.* Developing MOST 2015 N/A N/A  
 
Note: *: POLST form not available for review; N/S: not specified; AzMOST: Arizona Medical Orders for Scope of Treatment; COLST: 
Clinician Orders for Life Sustaining Treatment; DMOST: Delaware Medical Orders for Scope of Treatment; IPOST: Iowa Physician Orders for 
Scope of Tretament; LaPOST: Louisiana Physician Orders for Scope of Treatment; MOLST: Medical Orders for Life Sustaining Treatment; 
MOST: Medical Orders for Scope of Treatment; OkPOLST: Oklahoma Physician Orders for Life-Sustaining Treatment; POLST: Physician 
Orders for Life-Sustaining Treatment; POST: Physician Orders for Scope of Treatment; TOPP: Transportable Orders for Patient Preferences; 



















































Antibiotics IV fluids Transfer to 
Hospital 
Medication 
by any route 






N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
 

























































Frequency mentioned and locations 
 
Mentioned once  
 

























































Mentioned Twice  
 
Comfort + Limited 
treatment 
Limited + Full 
treatment 
Limited + separate 
section 





















































Mentioned three time 
 
Comfort + Limited + 
Full treatment 







































Total mentioned 32 (71.11) 33 (73.33) 45 (100) 45 (100) 45 (100) 42 (93.33) 41 (91.11) 
Not mentioned at all 13 (28.89) 12 (26.67) 0 0 0 3 (6.67) 4 (8.89) 
Total 45 (100) 45 (100) 45 (100) 45(100) 45 (100) 45 (100) 45 (100) 
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Chapter 4: Impact of Physician Orders for Life-Sustaining Treatment (POLST) Program 









The following chapter is a multivariate logistic regression analysis we conducted to examine the 
impacts of POLST maturity status on U.S. NH resident outcome. Guided by previous HN 
research work as well as Behavioral Model, we conducted analysis using multiple large datasets 
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The Physician Orders for Life-Sustaining Treatments (POLST) program was developed to 
enhance quality of care delivered at end-of-life (EoL). Although positive impacts of POLST 
program use on dying individual’s EoL care have been identified, the association between a 




Examine the impact of POLST program maturity status on elderly NH residents’ place of death. 
 
Design:  
A national, retrospective, cross-sectional analysis was conducted. 
 
Setting/ Participants: 
 Elderly NH residents not living in the Virgin Islands with Minimum Data Set (MDS) 3.0 
assessment(s) documented between 2012 and 2013 and who died in 2013 either in the NH or 
within 90 days of last NH discharge. The final sample included 595,152 individuals.  
 
Methods:  
The POLST program data were linked with the following national-level datasets: MDS, Vital 
Statistics Data, Master Beneficiary Summary File, Certification and Survey Provider Enhanced 
Reports, and Area Health Resource File. Stratifying residents on long-stay and short-stay, we 
used descriptive statistics and multivariate logistic regression models to examine the impact of 
POLST maturity status on nursing home residents’ place of death. 
 
Results:  
Controlling for individual and contextual variables, long-stay residents living in states where the 
POLST program was mature had 20% increased odds of dying in NHs (OR: 1.20; CI 1.02-1.43) 
compared to those who resided in states with non-conforming POLST program. Residents living 
in states endorsed or developing POLST status also had greater odds of dying in NHs (OR: 1.09; 
CI 0.98-1.21 endorsed status; OR: 1.12; CI 1.02-1.24 developing status) compared to the 
residents resided in states with non-conforming POLST status. No significant difference was 
noted for short-stay residents. 
 
Conclusion: 
Higher POLST maturity status was associated with greater likelihood of dying in NHs among 
long-stay nursing home residents. Our finding adds a new scientific evidence that a well-
structured advance care planning program such as POLST enhances care outcomes among 






There are over 16,000 U.S. nursing homes (NHs) serving nearly 1.5 million U.S. 
individuals at any time.195 It is estimated 1 in 4 Americans will die in NHs,196,197 and this number 
is projected to increase rapidly due to aging baby boomers, making end-of-life (EoL) care 
important in this setting.196,198,199 NHs are a major healthcare settings for patients living with a 
wide array of medical needs, ranging from post-acute conditions needing rehabilitation care to 
seriously ill patients with continuous nursing needs until the time of death.200,201 The vast 
majority of long-stay residents (i.e., those with a length of stay greater than 90 days) are the 
oldest of the old, individuals 85 years of age or older. These elderly residents suffer from 
complex health conditions and/or frailty,195,197  which is defined as a clinical state where an 
individual is at increased vulnerability of experiencing adverse health outcomes.202,203 For these 
vulnerable elderly residents, quality EoL care is a high priority.  
Many experts have proposed domains of EoL care that can serve as quality indicators 
including: symptom management and care satisfaction,204-206 advance care planning,205-207 
aggressiveness of care,196,208 and place of death for long-stay residents.206,209 Place of death for 
NH residents as an EoL quality care marker needs to be carefully considered because the care 
needs of long-stay NH residents are different than those of short-stay residents.210,211 Contrary to 
the goals of care in short-stay residents, which focuses on complete recovery and return back to 
community, the goals of care for long-stay residents align towards optimizing the quality of life 
and relief of suffering due to irreversible cognitive impairments,212-214 or progressively 
worsening physical impairments.215,216 For these residents, death in acute care facilities (e.g., 
emergency rooms or hospitals) is often deemed inappropriate, as the evidence shows that 
hospital transfers and subsequent deaths are closely associated with increased physical and 
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financial burdens,217 adverse health outcomes,218 and receipt of aggressive or unwanted medical 
interventions.209,219-222 For long-stay NH residents, hospital deaths have been identified as a 
marker for poor quality of EoL care.198,211,223-225 
The Physician Orders for Life-Sustaining Treatment (POLST) paradigm is an advance 
care planning program that was developed by medical experts in Oregon.19 POLST is a voluntary 
care planning tool, designed for individuals whose life expectancies are less than 12 months and 
are nearing the end of their lives.67,226-229 It allows a dying patient or their family to document 
specific care preferences through EoL care discussions, and facilitate patient-centered care 
planning. In 2004, the POLST program was publicly acknowledged by the Institute of Medicine 
(now known as National Academy of Medicine) as a program that can help achieve high quality 
EoL care.230  
           To set the standards for the program recognition, the national POLST program task force 
established 4 levels of program maturity status: mature, endorsed, developing, and non-
conforming.19,66 Mature status indicates the highest endorsement level, where the POLST 
program (e.g., California’s POLST) had become a part of the standard of care for individuals 
living with serious illnesses and limited life expectancies.66 Endorsed status indicates that the 
state POLST program (e.g., New York’s MOLST; M stands for medical) met key elements (e.g., 
having a single form for a state-wide usage), and have developed strategies for ongoing 
education and quality assurance.19,66 Developing status indicate that the state POLST program 
(e.g., Ohio’s MOLST) may be at an initial stage of development, and working towards statewide 
implementation. Lastly, non-conforming status (e.g., Nebraska’s POLST) indicates the POLST 
program either does not exist, or the state program does not meet the national POLST program 
endorsement criteria (e.g., no agreement on single form use).  
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While the use of POLST program was positively associated with increased hospice 
referrals,231,232 and EoL care discussions between care provider and terminally ill 
patients,148,28,233,234 an association between a state’s POLST program maturity status and the 
potential impacts it has on NH residents outcomes remain unanswered.  
Purpose 
 The purpose of this study is to examine the impact of POLST maturity status on the NH 
death among elderly residents. We hypothesized that the higher POLST maturity status was 
positively associated with a greater likelihood of dying in the NHs for long-stay residents.   
Method 




We used data collected from a previous published POLST program environmental scan,71 
linked with national-level administrative datasets: 2014 Vital Statistics File, 2012-2013 
Minimum Data Set 3.0 (MDS), 2014 Certification and Survey Provider Enhanced Reporting 
(CASPER), Area Health Resources File (AHRF) and the 2013 Master Beneficiary Summary File 
(MBSF).71 All data were linked by facility identification or location.  
The POLST environmental scan included data on: a) each state’s POLST maturity status; 
b) time the state first adopted POLST program (measured in years); and when applicable, c) year 
the state underwent change(s) in its POLST program maturity status (i.e., obtained the next level 
of maturity status) as well as d) the total length of time in years it took to advance to the next 
maturity status (e.g., developed to endorsed, endorsed to mature). Using this comprehensive 
dataset, we used data on each U.S. state’s POLST program maturity status, as of 2013. 
The Vital Statistics File was used to identify U.S. NH residents who died in 2013. Resident-level 
data were extracted from the MDS, which is federally mandated clinical assessment 
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documentation of NH residents who are residing in Centers of Medicare and Medicaid Services 
(CMS) certified nursing facilities.235 Detailed health assessments are recorded on MDS upon 
admission, quarterly thereafter, and when any significant changes (i.e., transfer or death) occur. 
An assessment contains individual’s demographic information, as well as health information 
(i.e., functional status).236 To obtain the most comprehensive resident-level data, we used the last 
available annual or the quarterly Omnibus Budget Reconciliation Act /Prospective Payment 
System (OBRA/PPS) assessment type prior to death for our long-stay group. For short-stay 
group, we utilized the PPS assessment type (i.e., 5-day, 14 day or 30 day scheduled assessment; 
whichever was the most recent). Resident characteristics extracted were: age at death, sex, 
race/ethnicity, and date of NH admission and discharge (when applicable); assessments on bed 
mobility, transfer, toilet use were extracted to compute the total activities of daily living (ADL) 
score for study sample.237 
The CASPER dataset contains facility level information collected during the state annual 
inspection surveys of NHs. Submission of such data is required by CMS, as a part of quality 
assurance system.238 Facility-level characteristics extracted included ownership, membership 
affiliation/ chain, bed size, occupancy rate, staffing and the presence of special units (i.e., 
Alzheimer’s and/or hospice unit). The decision to include the presence of special units in NHs 
was guided by recent publications,239,240  which noted that the presence of the special units were 
related to residents’ health outcomes.  
The AHRF is a county level dataset, which contains in-depth information on health 
resources, environmental, and sociodemographic characteristics of each county in the US.241 The 
following information were extracted from the dataset: proportion of elderly (>65 years) 
population in county, and median household income.  
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The MBSF contains data on all Medicare beneficiaries who are enrolled in, or entitled to 
receive Medicare benefit within a given calendar year.242 There are total 4 segments to the MBSF 
dataset: 1) beneficiary enrollment information summary; 2) chronic conditions; 3) cost and 
utilization; 4) national death index. We utilized chronic conditions segment, which informs 
whether an individual had select chronic health conditions in their last year of life. Chronic 
conditions identified through this segment were Alzheimer’s disease, dementia, chronic kidney 
disease (CKD), diabetes, cancer, and chronic obstructive pulmonary disease (COPD).  
Study Sample 
  
Using the 2014 Vital Statistics File, we identified 1,009,372 unique individuals who died 
in 2013. The sample process is depicted in Figure 5. Exclusions applied to our study sample 
were: individuals with no MDS assessment documented in 2012 or 2013 (n = 142,873), unable to 
merge with CASPER or AHRF data due to issues including inaccurate facility identifier or 
county code (n = 67,841), did not have MBSF information (n = 320), younger than 65 years of 
age, and living in the Virgin Islands (n = 33,947). Our final study sample included total of 
595,152 unique individuals. Guided by previous NH studies and based on our hypothesis,243-245 
we further classified our sample into long-stay (with consecutive length of stay equal or longer 




The outcome of interest was place of death, dichotomized as NH death = 1, non-NH 
death = 0. Using the resident’s last MDS assessment, NH death was yes if a) resident’s discharge 
placement indicated deceased, or b) MDS assessment type indicated death in facility. NH death 
was marked as no if a) MDS assessment type indicated discharge reporting and b) resident’s 
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discharge placement indicated that the resident was discharged to one of following settings: 
community; another NH facility; acute hospital; psychiatric hospital; inpatient rehab; 
Intellectual/ Development Disability (ID/DD) facility; hospice; long-term care hospital; or other. 
Predictor variables 
 
The main predictor of interest  was the POLST program maturity status: mature, 
endorsed, developing and non-conforming.71 Guided by previous NH studies, individual and 
contextual characteristics associated with place of death in NHs were also examined. These 
characteristics were classified according to the Gelberg-Andersen’s Behavioral Model (shown in 
Figure 4). This model identifies an individual’s access to healthcare services and/or pattern of 
healthcare as a function of three main domains: predisposing, enabling and need factors.125,246 
Individual characteristics included as the predictors of NH death were: resident’s age (65-70 
years, 71-75 years, 76-80 years, 81-85 years, 86-90 years, 91-95 years, 96-100 years, 101-110 
years), sex (male vs. female), race/ ethnicity (Non-Hispanic White, African American, American 
Indian, Asian, Hispanic, Native Hawaiian/Pacific Islander, or 2 or more race), marital status 
(married, never married, separated, widowed, or divorced), chronic conditions (present or absent 
of; cancer, COPD, CHF, diabetes, CKD, Alzheimer’s, dementia), and the total ADL score (range 
4-18).225,243,247-249 Facility level predictors were: presence of special unit (yes vs. no for; 
Alzheimer’s unit, hospice unit) and bed size (<50, 50-99, 100-199, >200).  
Other contextual variables that were controlled for included facility-related and county-
related characteristics. Facility-related characteristics were: NH type (for-profit, non-profit, 
government), affiliation or chain status (yes vs. no), occupancy rate (range 0-100 percent), 
staffing (measured in number of hours per resident day for: registered nurse, license practical 
nurse, and certified nurse assistant), profit status (non-profit, non-profit or government owned), 
 65 
 
proportion of elderly population ≥65 years (range: 1-40 percent), and median household income 
(low, middle, high),241,250 setting (metropolitan, urban, rural), and geographic regions (West, 
Midwest, Northeast or South).209,223,241,247  
 
Figure 4. Theoretical Framework and Variables Included  
note: ADL: activities of daily living; NH: nursing home; POLST: physician orders for life-sustaining treatment.  
Analysis 
Descriptive statistics (i.e., frequencies, means, standard deviations, and percentages) were 
used to summarize characteristics of study sample and NH facilities, stratified by stay types (i.e., 
long-stay, short-stay) and then the total sample combined. Bivariate analyses were conducted to 
investigate associations between baseline characteristics and NH death. Chi-square and t-test 
statistics were used to examine if there were significant differences between each variable in the 
model and NH death, across long and short-stay types.  
 Using multivariate logistic regression, we calculated associations between POLST 
maturity status and place of death, stratified by long and short-stay. To account for the non-
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independence of observations derived from repeated measures of NH facilities within the same 
county, we estimated county-clustered robust standard errors. Odds ratio (OR) and 95% 
confidence intervals (CI) were calculated. All analyses were conducted using SAS 9.4. 
Results 
Resident level characteristics  
Baseline characteristics of study sample are presented in Table 5. The total study sample 
included 595,152 unique elderly individuals who died in 2013. Forty eight percent of sample 
population were long-stay (n = 285,888) and 52% were short-stay residents (n = 309,264). 
Together, they represent a total of 6,241 NHs across the nation. Except for the presence of 
hospice unit (p = 0.09) within NH facilities, all other variables included in our study were 
significantly different across the long and short-stay group (p<.0001).  
The sample residents were predominantly female (61%), non-Hispanic White (85%), and 
died between the ages of 86-90 (24%). The average age at death for the total sample was 84 
years (SD ± 8.35). Nearly half (49%) of our sample were in oldest old age group, age 86 and 
older. Little over half of total sample (52%) reported their marital status as widowed. The 
proportion of those with widowed marital status were higher among long-stay residents (58%) 
than in short-stay (46%) residents (p<.0001). The most common chronic conditions seen across 
the stay types were CHF (50%) and CKD (48%). Although the total proportion of sample 
residents who suffered from Alzheimer’s disease were 29%, the proportion was much higher 
among long-stay residents than short-stay residents (41% vs. 17%, respectively, p<0.001). 
Similarly, the total proportion of cancer patients in our sample residents were 14%. However, the 
proportion of cancer patients were much higher among short-stay residents than long-stay 
residents (19% vs. 8%, respectively, p<.0001).  
 67 
 
Little over half (57%) of total sample residents died in NHs. NH deaths were more 
common among long-stay residents than short-stay residents (76% vs 41% respectively, 
p<.0001). 
State POLST program characteristics 
The majority of states (59%) had a POLST program with developing maturity status, 
followed by endorsed (35%), non-conforming (5%) and mature (1%). Nearly all (95%) of 
sample residents (i.e., 95% of all long-stay and 96% of all short-stay residents) were from the 
states where the POLST program had developing or higher maturity status.  
Contextual characteristics 
The contextual variables included in our study are presented in Table 6. Most of sample 
facilities had for-profit status (72%), and were chain affiliated (57%). More than half (59%) of 
sample NHs were equipped with 100 to 199 beds, with an average occupancy rate of 84% (± 
13.60). The average nursing staff (measured in number of hours per resident day) varied; 0.74 
hour per resident day for registered nurses (SD ± 0.43), 0.84 hour per resident day for licensed 
practical nurses (SD ± 0.35), and 2.16 hour per resident day for certified nursing assistant (SD ± 
0.65). Twenty two percent of all NHs were equipped with Alzheimer’s unit, whereas only a 
small fraction had hospice unit (1%).  
Sample NHs were mainly located in the South (36%), and in metropolitan areas (81%). 
An average proportion of elderly population per county was 10% (SD ± 3.27), and the median 
household income per county was $53,334.54 (SD ± 13,957.46) 
Impact of POLST maturity status on NH death 
 Table 7 shows the result of multivariate logistic regression analysis stratified by stay 
type. In the long-stay residents, the odds of dying in NHs were 20% higher in states that had 
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mature POLST programs compared to states where the POLST program was non-conforming 
(OR: 1.20, 95% CI 1.02-1.43). Similarly, residents in a state where the POLST program had 
endorsed or developing status had 9% (OR: 1.09, 95% CI 98-1.21) and 12% (OR: 1.12, 95% CI 
1.02-1.24) increased odds of dying in NHs compared to residents in states where the POLST 
program was non-conforming.  There was no significant difference for short-stay residents.  
Predictors of NH death by Stay Type 
In long-stay residents, older age groups had progressively higher likelihood of dying in 
NHs (ORs: 1.07-4.44). Older age and the higher likelihood of NH deaths remained constant in 
the short-stay group (ORs 1.04-2.88). Although odds of dying in NHs were not statistically 
different between the reference group (65-70 years) and the second youngest age group (71-75 
years); all other age groups had progressively higher odds of dying in NHs (OR: 1.04, 1.19, 1.35, 
1.63, 1.91, 2.23 for age group 76-80, 81-85, 86-90, 91-95, 96-100, 101-110, respectively) 
In both long and short-stay residents, individuals who were never married, divorced, 
separated, or widowed had higher likelihood of dying in NHs (ORs: 1.10-1.57). In a long-stay 
group, separated marital status was the strongest predictor of NH deaths (OR: 1.27, 95% CI 1.14-
1.40) compared to the married status. On the other hand, never been married was the strongest 
predictor of NH deaths for the short-stay residents (OR: 1.52, 95% CI 1.47-1.57).  
In the long-stay residents, compared to White race, all other race groups (i.e., African 
American, American Indian, Asian, Hispanic, Native Hawaiian/ Pacific Islander, 2 or more race) 
had lower odds of dying in NHs (ORs: 0.66-0.71). In the short-stay residents, those who were 
Asian or multiple race (e.g., 2 or more races) had higher odds of dying in NHs (OR 1.22, 1.35, 
95% CI 1.07-1.38, 1.15-1.58, respectively). 
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Having COPD increased likelihood of death in NHs compared to those who did not have 
COPD (OR: 1.49, 95% CI 1.45-1.53 long-stay; OR: 1.20, 95% CI 1.18-1.23 short-stay). 
Alzheimer’s disease also increased likelihood of dying in NHs, compared to those who did not 
have Alzheimer’s diagnosis (OR: 1.49, 95% CI 1.44-1.54; OR: 1.45, 95% CI 1.42-1.48, 
respectively). An inverse relationship was noted in likelihood of dying in NHs for the NH 
residents suffering from cancer (OR 0.83, 95% CI: 0.81-0.86 for long stay; OR: 1.18, 95% CI 
1.15-1.20 for short stay).   
Facility characteristics associated with greater odds of dying in NHs were the presence of 
Alzheimer’s unit (OR: 1.15, 95% CI 1.11-1.20 for long-stay; OR 1.16, 95% 95% CI 1.08-1.21 
for short-stay), and the smaller NH facilities with less than 50 beds (OR: 1.16, 95% CI: 1.09, 
1.24 for long-stay; OR1.12, 95% CI: 1.10-1.28 for short-stay), compared to a the reference group 
(NHs with bed size 50-99). NHs equipped with hospice unit was a significant predictor of NH 
death in both long-stay (OR: 1.05, 95% CI: 0.88-1.24) and short-stay group (OR: 1.15, 95% CI: 
0.83-1.59). 
Discussion 
This is the first study to examine the association between the POLST program maturity 
status and NH deaths. Use of multiple large datasets, combined with a primary data collected 
through previous POLST study provide a new insight to better understand the impact of the 
POLST program maturity status and an associated patient outcome. Controlling for individual 
and contextual characteristics, we found that the higher POLST maturity status was positively 
associated with greater odds of dying in NHs, among long-stay residents.  
While the data used in this study do not allow for assessing individual preferences and 
completion of POLST forms, the notable finding of a significant relationship between the state’s 
POLST maturity status and increased NH death in long-stay residents, implies that the state-wide 
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adoption of POLST can promote positive care outcomes, beyond the individual resident’s 
POLST form completion status. Spill-over is a term that explains the effects of an intervention on 
individuals who did not directly receive intervention, but who were connected to intervention 
recipients through social proximity.251 It is often mentioned in NH studies where researchers 
witness an overall improvement of care outcome after initiating a new program that is designed 
for a target population (e.g., hospice program for dying patients).113,114,243,251-254 Miller and 
colleagues reported that when the NH facility had higher number of hospice program enrollees, 
indicating higher exposure to a specialized EoL care program for all residents, care outcomes 
such as better management of pain,81 more frequent pain assessment,79,81 and reduced number of 
burdensome transfers to hospitals were seen throughout all residents, regardless of their hospice 
enrollment status.114,115,124 This spillover phenomenon is thought to be caused by diffusion of 
knowledge.255 That is, a newly implemented program or protocol generates new knowledge, 
which then fuels changes in the practice pattern or culture of institution, influencing care 
outcomes in general population. The pattern we observed, higher POLST maturity status and 
greater odds of dying in NHs among long-stay residents, may be in part due to increased 
knowledge generated with the initiation of state-wide adaptation of the POLST program that 
aims to emphasize importance of delivering patient-centered care for those who are nearing EoL.  
While we observed significant associations between NH deaths and the state’s POLST 
status (developing and mature), the positive association between endorsed status and NH deaths 
lacked significance. The previous research on POLST has only looked at care outcomes 
measured from those who completed the POLST forms,73,232,233,256-260 making it difficult to draw 
a comparison with our results. It is possible that there could be a plateau period, where relatively 
small efforts are being made to change the practice pattern once the state’s POLST program 
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obtains endorsed status, until they achieve the next, and the highest status, mature. It is also 
probable that NHs located in states with endorsed POLST status have an improved awareness on 
the importance of delivering specialized EoL care for dying patients, resulting in increased 
number of timely referrals to specialized EoL care facilities such as hospices or palliative care 
centers. Or, it could also be that those NHs put more efforts to identify dying patients’ preferred 
place of death and allow them to be discharged from NHs near the time of death to honor patient 
wishes. Reasons behind the lack of significant association between the endorsed POLST status 
and NH deaths is an important question left to be answered through future studies.  
Predictors of NH deaths 
We found several resident-level factors that were significantly associated with NH death. 
Specifically, older age, White race, and living with chronic conditions (e.g., COPD, Alzheimer’s 
disease, and/ or Dementia) were shown to increase the residents’ odds of dying in NHs in both 
short and long-stay groups. Previous NH studies, which explored predictors of NH death in 
elderly residents, also reported similar findings; advanced age,119,261-264 and chronic conditions 
were the most commonly found predictors of NH death for elderly residents living with serious 
illnesses.261,262,264-266  
Although we noted a significant association between the race/ ethnicity and odds of dying 
in NHs in both stay groups, previous studies mixed results. For example, in a recent study of 
elderly individuals living with serious illnesses, authors did not find significant associations 
between individual’s race/ ethnicity and the final place of death (e.g., hospital vs. non-hospital 
setting).267 In another study, where authors examined the factors associated with in-hospital 
deaths among NH residents in two groups; non-Hispanic Black and non-Hispanic White 
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residents. It was noted that Black race was associated with a significantly higher odds of dying in 
hospitals, as opposed to NHs, when compared to their White counterparts.268 
Male sex was noted to be significantly associated with the increased risk of NH death, in 
our short-stay group. While many studies have explored sex differences and the associated risk 
of mortality among NH residents,262,269-273 none of identified studies reported specific location of 
death (e.g., NH vs. hospital). Moreover, the majority of available studies limited their study 
sample to disease-specific groups (e.g., Alzheimer’s disease),270,271,273 or by their cognitive 
fuction.262,269 For instance, Lupane and colleagues found that male sex was a significant 
predictor of mortality among elderly NH residents living with Alzheimer’s disease.270 Another 
study also showed that male sex was significantly associated with increased mortality, among 
elderly residents living with Parkinson’s Disease.271  
There are few recommendations for future studies. First, future studies should conduct 
similar analysis using different measures that can be a surrogate measure for the level of POLST 
development, other than the maturity status. It can be a measure of total length of time since the 
POLST program was first initiated, or a composite score generated with different elements that 
are deemed important and relevant to the POLST program (e.g., research efforts, staff awareness, 
actual number of POLST form completed). By doing so, it can help determine if findings are 
consistent throughout studies and identify areas that needs further improvements.    
Second, although we specifically focused NH death as our outcome of interest, future 
studies should examine the impact of POLST program/ maturity status on different outcomes 
(e.g., receipt of concordant interventions, number of hospice enrollments). Lastly, future research 
should also explore if different level of maturity status is associated with best practices in EoL 




In last few years, a significant research effort has been made to provide scientific 
evidence on benefits of high quality EoL care provided to vulnerable population. And previous 
studies unanimously support that best practices in EoL are those that maximize quality of 
remaining life, while minimizing avoidable care transfers. Results of this study call for the 
continued effort to adopt nationwide implementation of the POLST program that aims to deliver 
goal-concordant EoL care to elderly living with serious illnesses. It also calls for continued 
research efforts to identify best practices in EoL, and how best to deliver a type of care that 
aligns with dying patient’s wishes, goals and values.  
Limitations 
 
There are several limitations to this study. Rather than dichotomizing our outcome of 
interest as NH vs. non-NH death, examining other outcomes (i.e., death occurring in community) 
could have offered findings that were not discussed in our study. Plus, specifying place of death, 
beyond NH settings, could have potentially shed light to the possible associations between the 
POLST maturity status and one’s likelihood of dying at specific setting (e.g., home, NH, 
hospital). However, this was not feasible with the datasets we used. For instance, the current 
MDS 3.0 assessment includes an item that can help identify if the resident’s last discharge 
(before the date of death) was to the community, or other facilities such as acute care hospital. 
The challenge that exists in using community as a measure of deaths that occurred at home is that 
the term community in MDS 3.0 includes other settings (i.e., assisted living care settings, or 
group homes). Needless to say, those settings are not the same as one’s residence.  
A similar problem arose when the patient’s discharge placement indicated a discharge to 
a hospice setting. Although it may seem more appropriate that dying patient should receive 
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specialized care at hospice settings, it was unclear whether it captures discharges to a separate 
hospice care center, or a hospice unit within the same facility.  
Another limitation of our study is related to the study design. Due to the nature of cross-
sectional analysis, the relationship we examined between the POLST maturity status and NH 
death can only be interpreted as an association, and not causation. Statistical methods such as 
fixed effect model allows an analysis of the impact that variables carry over time. While it is 
useful to apply, we unable to apply state fixed effect as there was no variation in state POLST 
program maturity status.  
Future study that addresses similar research question should be conducted to better 
understand the impact of the POLST program on individual level outcomes as well as the 
differences in maturity status and associated outcomes. While randomized control trials may not 
be feasible, a well-designed prospective studies and longitudinal studies can certainly add body 
of knowledge on this important topic.  
Conclusion 
 Controlling for individual and contextual variables, higher POLST maturity status is 
positively associated with greater likelihood of dying in NHs, among long-stay residents. 
Findings from our study adds to the body of science that well-structured advance care planning 
programs, such as POLST, can promote best practices in EoL.  
State-wide implementation of the POLST program, and continued efforts to meet high 
standards of quality EoL care (evidenced by higher maturity status) can result in positive health 
outcomes for elderly patients suffering from serious illnesses. State, or national-wide initiatives 
focusing on quality improvement at EoL should therefore be widely disseminated and adopted to 
































Figure 5. Sampling Process 
Note: AHRF: area health resource file; CASPER: certification and survey provider enhanced reports; MBSF: master beneficiary summary file; 
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(n = 285,888) 
Short-stay residents 
(n = 309,264) 
Total sample 
(n = 595,152) P value¹ 
Individual characteristics, n (%) 
Sex      <.0001 
Female 194,161 (67.92) 167,473 (54.15) 361,634 (60.77)  
Race/ Ethnicity    <.0001 
African American 28,775 (10.24) 25,838 (8.61) 54,613 (9.39)  
American Indian 659 (0.23) 653 (0.22) 1312 (0.23)  
Asian 3,891 (1.38) 4,204 (1.40) 8,095 (1.39)  
Hispanic 9,769 (3.47) 9,282 (3.09) 19,051 (3.28)  
Two or more race 577 (0.21) 598 (0.20) 1,175 (0.20)  
Native Hawaiian 272 (0.1) 344 (0.11) 616 (0.11)  
Non-Hispanic White 237,193 (84.37) 259,270 (86.37) 496,463 (85.40)  
Age at death     
65-70 17,237 (6.03) 31,332 (10.13) 48,569 (8.08) <.0001 
71-75 21,330 (7.46) 34,395 (11.12) 55,725 (9.29)  
76-80 33,574 (11.74) 46,933 (15.18) 80,507 (13.46)  
81-85 55,148 (19.29) 65,855 (21.29) 121,003 (20.29)  
86-90 71,612 (25.05) 71,140 (23.00) 142,752 (24.03)  
91-95 58,318 (20.40) 42,569 (14.64) 100,887 (17.52)  
96-100 23,824 (8.33) 12,765 (4.13) 36,589 (6.23)  
101-110 4,845 (1.69) 1,575 (0.51) 6,120 (1.10)  
Marital Status     
Divorced 25,933 (9.18) 24,509 (8.12) 50,442 (8.64) <.0001 
Married 62,637 (22.18) 111,973 (37.12) 174,610 (29.89)  
Never Married 27,671 (9.80) 22,751 (7.54) 50,422 (8.63)  
Separated 2,579 (0.91) 2,418 (0.80) 4,997 (0.86)  
Widowed 163,596 (57.93) 140,027 (46.42) 303,623 (51.98)  
Chronic Conditions     
Alzheimer 116,110 (40.61) 53,939 (17.44) 170,049 (28.57) <.0001 
Dementia 103,570 (36.23) 81,750 (26.43) 185,320 (31.14) <.0001 
CKD 122,948 (43.01) 162,208 (52.45) 285,156 (47.91) <.0001 
CHF 140,126 (49.01) 159,924 (51.71) 300,050 (50.42) <.0001 
Diabetes 109,363 (38.25) 109,918 (35.54) 219,281 (36.84) <.0001 
Cancer 23,294 (8.15) 58,484 (18.81) 81,478 (13.69) <.0001 
COPD 66,051 (23.10) 99,614 (32.21) 165,665 (27.84) <.0001 
Death in NH 216,182 (75.62) 125542 (40.59) 341724 (57.42) <.0001 
     
Note: ADL: activities of daily living; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; LPN: licensed practical 
nurse; NH: nursing home; SD: standard deviation;  
¹: P value from chi-square tests for categorical variables, and t test for continuous variables 












Table 6. Description of NH Sample and Bivariate Associations, by Stay Type. 
 
Characteristic Long-stay residents 
(n = 285,888) 
Short-stay residents 
(n = 309,264) 
Total sample 
(n = 595,152) 
P value¹ 
Independent variable, n (%) 
POLST maturity status    <.0001 
Mature 3,377 (1.18) 4,829 (1.56) 8,206 (1.38)  
Endorsed 101,632 (35.55) 108,566 (35.10) 210,198 (35.32)  
Developing 167,370 (58.54) 182,356 (58.96) 349,726 (58.76)  
Non-conforming 13,509 (4.73) 13,513 (4.37) 27,022 (4.54)  
Facility characteristics, n (%) 
Facility type    <.0001 
For-profit 198,680 (69.50) 230,622 (74.57) 429,302 (72.13)  
Non-profit 70,245 (24.57) 69,320 (22.41) 139,565 (23.45)  
Government 16,963 (5.93) 9,322 (3.01) 26,285 (4.42)  
Affiliation/ Chain 154,981 (54.21) 184,326 (59.60) 339,307 (57.01) <.0001 
Bed size    <.0001 
< 50 8,779 (3.11) 10,844 (3.55) 19,623 (3.34)  
50-99 71,803 (25.44) 75,284 (24.63) 147,087 (25.02)  
100-199 161,173 (57.11) 184,343 (60.32) 345,516 (58.78)  
>200 40,462 (14.34) 35,135 (11.50) 35,135 (11.50)  
Occupancy rate 85.06 (12.89) 83.82 (14.19) 84.41 (13.60) <.0001 
Staffing     
RN 0.69 (0.34) 0.81 (0.49) 0.75 (0.43) <.0001 
LPN 0.82 (0.33) 0.86 (0.37) 0.84 (0.35) <.0001 
CNA 2.44 (0.60) 2.48 (0.69) 2.16 (0.65) <.0001 
Occupancy rate 85.06 (12.89) 83.82 (14.19) 84.41 (13.60) <.0001 
Special unit     
Alzheimer’s unit 62,853 (21.99) 54,355 (17.58) 117,208 (19.69) <.0001 
Hospice unit 2,904 (1.02) 3,279 (1.06) 6,183 (1.04) 0.09 
County level characteristics mean (SD) 
Elderly proportion 10.11 (3.86) 9.95 (3.59) 10.03 (3.72) <.0001 
Median household income 52484.29 (13670.26) 54120.59 (14172.54) 53334.54 (13957.46) <.0001 
County level characteristics, n (%) 
Setting    <.0001 
Metropolitan 221548 (77.50) 261631 (84.60) 483,179 (81.19)  
Urban 57740 (20.20) 43867 (14.19) 101,607 (17.07)  
Rural 6569 (2.30) 3750 (1.21) 10,319 (1.73)  
Geographic region    <.0001 
Midwest 82,204 (28.75) 79,062 (25.57) 161,266 (27.10)  
Northeast 72,731 (25.44) 71,675 (23.18) 144,406 (24.27)  
South 102,059 (35.70) 110,709 (35.80) 212,768 (35.75)  
West 28,891 (10.11) 47,767 (15.45) 76,658 (12.88)  
 
Note: CNA: certified nursing assistance; LPN: licensed practical nurse; NH: nursing home; POLST: physician orders for life-sustaining 
treatment; SD: standard deviation;  
*: measured in full-time equivalent hours per resident per day 










Table 7. Multivariate logistic regression model by NH stay type 
Predictors Long-Stay Residents Short-Stay Residents 
 OR (95% CI) OR (95% CI) 
POLST maturity status     
Mature 1.20 (1.02-1.43) 0.90 (0.75-1.09) 
Endorsed 1.09 (0.98-1.21) 1.12 (0.99-1.26) 
Developing 1.12 (1.02-1.24) 0.97 (0.86-1.10) 
Non-Conforming Reference Reference 
Age (in years)     
65-70 Reference Reference 
 71-75  1.14 (1.07-1.20) 1.008 (0.98-1.04) 
 76-80  1.27 (1.22-1.33) 1.09 (1.04-1.13) 
81-85  1.46 (1.41-1.52) 1.23 (1.19-1.27) 
86-90  1.71 (1.65-1.78) 1.41 (1.35-1.47) 
91-95  2.12 (2.03-2.21) 1.70 (1.63-1.78) 
 96-10  2.74 (2.60-2.88) 2.02 (1.91-2.14) 
101-110  4.02 (3.63-4.44) 2.54 (2.23-2.88) 
Sex     
Female Reference Reference 
Male 0.995 (0.97-1.01) 1.07 (1.05-1.09) 
Marital Status     
Married Reference Reference 
Never Married  1.14 (1.10-1.19) 1.52 (1.47-1.57) 
Divorce  1.17 (1.13-1.22) 1.38 (1.33-1.43) 
Separated   1.27 (1.14-1.40) 1.31 (1.18-1.45) 
Widowed  1.12 (1.09-1.15) 1.21 (1.18-1.23) 
Race/ Ethnicity     
Non-Hispanic White Reference Reference 
African American 0.69 (0.66-0.73) 0.85 (0.81-0.89) 
American Indian 0.68 (0.55-0.82) 0.87 (0.72-1.05) 
Asian  0.66 (0.62-0.71) 1.22 (1.07-1.38) 
 Hispanic 0.68 (0.64-0.73) 0.90 (0.84-0.95) 
 Native Hawaiian/ 
Pacific Islander 0.66 (0.50-0.87) 0.80 (0.64-0.99) 
2 or more race  0.71 (0.59-0.86) 1.35 (1.15-1.58) 
Chronic Conditions     
Cancer 0.83 (0.81-0.86) 1.18 (1.15-1.20) 
COPD 1.49 (1.45-1.53) 1.20 (1.18-1.23) 
CHF 0.72 (0.70-0.73) 0.80 (0.78-0.81) 
Diabetes 0.92 (0.90-0.94) 0.97 (0.95-0.99) 
CKD 0.49 (0.47-0.49) 0.75 (0.73-0.76) 
Alzheimer’s   1.49 (1.44-1.54) 1.45 (1.42-1.48) 
Dementia  1.33 (1.30-1.37) 1.24 (1.21-1.26) 
Alzheimer’s Unit 1.15 (1.11-1.20) 1.14 (1.08-1.21) 
Hospice Unit 1.05 (0.88-1.24) 1.15 (0.83-1.59) 
Bed Size     
50-99 Reference Reference 
<50 1.16 (1.09-1.24) 1.18 (1.10-1.28) 
100-199 0.92 (0.90-0.95) 0.82 (0.79-0.86) 
>200 0.81 (0.76-0.89) 0.72 (0.67-0.77) 
Note: CI: confidence interval. CHF: congestive heart failure; CKD: chronic kidney disease; COPD: chronic obstructive 
pulmonary disease; NH: nursing home; OR: odds ratio 
All models controlled for state-level clustering effects, state-level fixed effects, sociodemographic characteristics (i.e., total ADL 
score), and facility level characteristics (i.e., staffing, occupancy rate, facility type, affiliation/chain status, setting, geographic 
region), county level characteristics (i.e., proportion of elderly, median household income) 
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Chapter 5: Synthesis 
 
This closing chapter first synthesizes findings of research studies included in this dissertation. It 
then presents discussion of research findings in the context of existing evidence and implications 
for policy, clinical practice and future research. Finally, strengths and limitations of studies 






Summary of Study Findings 
Our systematic review, described in chapter 2, aimed to synthesize scientific evidence on 
the rate of congruence between the care wishes documented on the Physician Orders for Life 
Sustaining Treatments (POLST) form and the actual care delivered during end-of-life (EoL) care 
journey. High rate of congruence was noted on the level of medical care requested (e.g., comfort 
-focused, limited or full interventions); preferred care settings (e.g., hospital or nursing home; 
NH); and the delivery of cardiopulmonary resuscitation (CPR). Mixed concordance rates were 
found in the use of antibiotics and feeding tubes at EoL. It was noteworthy that none of patients 
who opted not to receive CPR had unwanted CPR performed at the time of death.  
Our study results were in line with the findings that were reported from the previous 
review. Hickman and colleagues authored a 2015 study,21 which found high congruence in CPR 
and hospital transfer interventions, with low to mixed rates for feeding tube and antibiotics 
usage. Although the Hickman study had a similar research question our systematic review 
offered broader and generalizable findings by expanding study inclusion criteria. That is, while 
the a previously review only examined the sample population who were residing in clinical 
settings (e.g., hospital or hospice), we included study sample to that of community indwellers, 
and home-based care recipients. 
 The environmental scan study we conducted in chapter 3 was to examine the current 
status of the POLST program implementation across the nation. Using a national and state-
specific POLST program websites, we were able examine: whether each state implemented the 
POLST program; maturity status of state POLST programs; year it established/ endorsed/ 
matured (when applicable); and specific care options captured on the state POLST forms. In 
addition, we extracted care options that were related to infection and symptom management, to 
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investigate whether presence of such EoL care options were significantly associated with the 
POLST maturity status.  
This study revealed that the majority states (n = 48, 98%) were actively participating in 
the POLST program. There were 19 states (39%) with endorsed status, 3 states (6%) with mature 
status. While care options for the CPR delivery, oxygen use, hospital transfer and medication 
administration were present in nearly all available POLST forms (n = 45, 100%), antibiotics use 
was the least frequently mentioned option of all (n = 32, 71%). We also found that there no 
association between the maturity status and the presence of infection/symptom management 
options. Being the first study to ever examine current status of the POLST program across the 
nation, this study significant contributed to the knowledge of where we stand, in terms of effort 
to enhance EoL care processes and deliveries.  
Lastly, we conducted quantitative analysis to examine the impact of POLST maturity 
status on NH death, using a multivariate logistic regression model. Our sample constituted of a 
nationally representative sample of elderly individuals, who died in 2013 and resided in NHs 
between 2012-2013. Variables used in the model were guided by Andersen’s Behavioral Model, 
as well as previous research studies that explored risk factors related to place of death among 
elderly individuals.   
Controlling for all other factors (i.e., individual and contextual characteristics), increased 
odds of dying in NHs were noted among long-stay residents residing in higher POLST maturity 
status (non-conforming status serving as reference). There was no significant association noted 
in short-stay residents. This was the first study that used a novel approach to examine the impact 
of the POLST status and associated outcomes within NH settings. In addition, we were able to 
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identify several important factors, that were shown to significantly associated with NH deaths in 
vulnerable population. Summary of findings from each study is depicted in Table 8.  
Table 8. Summary of Each Study and Its Findings 
 
Aim: Synthesize the evidence on the congruency between Physician 
Orders for Life-Sustaining treatment (POLST) documentation and 
subsequent care delivered to End-of-Life (EoL) for U.S. residents
Study 1
•Title: Congruence between End-of-Life Care Preferences using Physician Orders for Life-
Sustaining Treatment (POLST) documentation and subsequent care delivered: Systematic 
Review
•Findings
•Eight research studies included, examined the rate of congruence between care wish 
documented and delivered, from carious care settings (e.g., Nursing Home, Hospital, 
Community, and Hospice care settings)
•The range of congruence was: 84-100% for Cardio-pulmonary Resuscitation; 85-87% for 
hospital transfers; 64-86% for antibiotics use; and 50-94% for feeding or IV fluid use
Aim: Examine current status of POLST program implementation 
across U.S., and identify state variations in how infection and physical 
symptom management options are captured on state POLST forms
Study 2
•Title: Variations in Physician Order for Life-Sustaining Treatment (POLST) program across 
the nation: Environmental Scan
•Findings
•Total 50 U.S. states and Washington D.C. included in analysis
•Mature status (n = 3), Endorsed (n = 20), Developing (n = 24), Non-Conforming (n =4)
•Antibiotics option assessed on 32 forms (71%), IV fluid option assessed on 33 forms (77%)
•Hospital transfer, Medication administration and Oxygen use assessed on all forms (100%)
Aim: Controlling for other contextual and individual characteristics, examine 
impacts of POLST maturity status on the place of death (i.e., Nursing Home 
death) among elderly individuals residing in U.S. nursing homes
Study 3
•Title: Higher Maturity Status of Physician Orders for Life-Sustatining Treatment (POLST) and 
Greater Likelihood of Dying in Nursing Homes Among Long-Stay Residents
•Methods: Multivariate logistic regression with clustering at county level
•Findings
•Long-stay residents living in states where the POLST program was mature had 20% increased 
odds of dying in NHs (OR: 1.20; 95% CI 1.02-1.43) compared to non-conforming status
•Endorsed or developing POLST status increased odds of dying in NHs (OR: 1.09; 95% CI 
0.98-1.21 endorsed status; OR: 1.12; 95% CI 1.02-1.24 developing status)
•No significant difference was noted among short-stay residents
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Study Findings and Implications for Policy, Clinical Practice and Future Research 
Our study findings reflect that the POLST program is generally effective in ensuring 
goal-concordant care at EoL, and the implementation of state-wide POLST program is associated 
with positive likelihood of NH death. However, the most variations observed in concordant care 
was in antibiotics use. It was not surprising that our findings generated from the POLST program 
environmental scan also indicated that the patient preference for antibiotics usage was the least 
frequently mentioned option, of all available POLST forms we examined.   
Based on the previous finding, as high as 75% of NH residents are exposed to 
inappropriate antibiotics and many therapies are initiated against the patient’s own wish,22-25 it is 
important that there be a national, or facility-level policy to reinforce a timely assessment of EoL 
care preferences among seriously ill patients. In NH settings, this system can be incorporated as 
a part of MDS assessment, which can provide further benefit: a routine (quarterly) assessment.  
As of 2019, California is the only state where the MDS assessment contains a separate 
section, section S (shown in figure 6), that prompts an assessment of whether the NH resident 
has a California POLST form completed and placed in chart.26 While California is abiding to the 
POLST program requirement (i.e., the POLST form completion must remain voluntary),19 
eliciting the presence of the POLST form became a routine part of NH resident assessments. 
Implementing a similar system can provide a critical opportunity where further information on 
the POLST program be provided, and subsequent conversations regarding EoL care be held in 
timely fashion.   
In existing studies, researchers identified two important provider-related barriers to the 
use of ACP tools and EoL care discussions: unfamiliarity with different ACP tools and lack of 
knowledge/ training in EoL conversation.27-31 While research evidence for the positive impacts 
of ACP on patient outcomes are accumulating,32-35 little is known the ways we can meet 
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educational needs of care providers. As lack of competency and little trainings would hinder 
translation of scientific knowledge to daily practices, it is important that we explore opportunities 
to train clinical staff, who would then serve as key persons in promoting quality EoL care.  
Future Research Directions 
Continued research efforts to identify the impact of the POLST program on diverse 
patient populations (i.e., young adults, ethnic minorities and homecare patients) and their 
caregivers can strengthen further dissemination of the POLST program. Furthermore, there is a 
lack of knowledge on the economic benefits of POLST program implementation in healthcare 
settings. Although it has been reported that the POLST program may reduce burdensome care 
transfers between NHs and emergency room/ intensive care use, cost-savings and economic 
benefits of POLST initiation within care facilities remain unknown.  
Strengths and Limitations 
Studies included in this dissertation implemented different research methods to explore 
outcomes of the POLST program. Our systematic review, which was guided by Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist, generated 
generalizable research findings by broadening eligibility criteria. In a previously published 
systematic review, the authors limited their study selection to institutional settings (i.e., hospitals, 
hospices and NHs). However, we noted that many of the POLST program users are residing in 
community care settings,36,73 and that degrees in which POLST wishes are respected by 
emergency care responders were scarce.274 Therefore, we expanded our study inclusion to the 
studies that examined the patient outcomes regardless of their care settings. As a result, we not 
only were able to generate updated findings on effectiveness of the POLST participation on 
receipt of preferred care, but also provided more generalizable findings.  
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In our environmental scan study, we developed a data collection tool and extracted 
relevant information that appeared on the most recent copy of state-level POLST forms. This 
provided a valuable opportunity to highlight similarities and differences in type of EoL care 
options that are currently captured on POLST forms and offered a comprehensive examination of 
areas that may warrant further examination such as those that can strengthen inter-state 
transferability of care wishes and standardization of the POLST form.  
By using multiple large datasets in our quantitative study, and by incorporating our 
primary dataset (collected during our environmental study), we utilized scientifically rigorous 
methodology to examine the impacts of the POLST program maturity status on U.S. NH 
residents’ care outcomes. In addition, our nationally representative study sample enhanced the 
generalizability of our study findings. County-level clustering, which accounted for repeated 
measures of unique NH facilities, added robustness to our study outcome estimates.  
Nonetheless, we acknowledge that there are several limitations. In our systematic review 
conducted in chapter 2, it is possible that relevant research findings were missed due to issues 
related to: exclusion of grey literature; or exclusion criterion on the language or study types. Due 
to the tendency that studies reporting significant findings are more likely to be published than 
those without significant findings (i.e., publication bias) it is possible that we missed important 
study findings relevant to our research question. In addition, we limited our literature search to 
articles that were written in English language only, and quantitative research designs, and 
published in peer-reviewed journals. With such criteria, it is possible that we may have missed 
findings that may/ may not align with results we reported.  
In both chapters 3 and 4, we did not include potential measures that can be indicative of 
actual POLST program usage among target population (e.g., number of POLST forms completed 
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per facility/state, and/or POLST forms submitted through state e-registry). Although it would 
have been ideal to include such information to generate more comprehensive research findings, 
we felt it remained out of scope of this dissertation. By failing to consider other measures than 
the maturity status as the level of program advancement, we may have inadvertently over-
estimated the potential impact of the state’s POLST maturity status on place of death. When 
interpreting our study results identified in both chapters 3 and 4, it should be taken into 
consideration that due to cross sectional study design implemented, our findings does not show 
causation, but only the association.   
In the large datasets utilized for our multivariate regression model, covered in chapter 4, 
specific locations of patient death beyond NHs were not identified. Although we considered 
alternative measures (i.e., using community discharge prior to death as indication of death 
occurred at home) there was insufficient scientific evidence to conclude that community setting 
can serve as surrogate measure to one’s own residence. Similarly, we were unable to determine if 
non-NH death captured in our study sample was related to specific patient requests to be 
transported to non-NH care settings. It was probable that those who died in non-NHs had  
specifically requested for a care transfer, or a care transfer at EoL was needed to enhance 
comfort of a dying patient. Either cases represent a high-level of patient-centered EoL care 
delivery and should be looked at as the best practices that increased care concordance.  
Conclusion 
The POLST program provides an important opportunity to facilitate EoL care discussions 
that reflect a dying patient’s care wishes. It is an ACP tool that shows a high concordant rate 
between care that one wishes to receive, and actual care delivered at EoL. Since it was 
introduced to the public in early 1990s, the POLST program has been widely adopted in various 
healthcare settings (e.g., hospitals and NHs) and continues to be actively disseminated 
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throughout the nation. The positive association observed between the higher POLST maturity 
status and a higher likelihood of dying in NH facilities among long-stay NH residents is 
promising in that the POLST program can promote positive changes in the outcomes of EoL 
patients, most likely through spill-over effects.  
Findings reported in this dissertation can serve as evidence-based guidance that supports 
the importance of delivering high-quality EoL among those who are living with advanced 
illnesses and/or chronic conditions. Increased awareness on the importance of ACP, and the 
positive outcomes associated with the use of POLST program can also help transform the culture 
of EoL care; from excessive use of interventions causing protracted death and dying, to the 
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POLST Environmental Study Data Collection Tool 
 
 
Start of Block: Section 1 : POLST national program website scan 
 
























Q1 Status level 
o Mature  (1)  
o Endorsed  (2)  
o Developing  (3)  
o Non-conforming  (4)  
o None  (5)  
 
Skip To: End of Survey If Status level = None 
 
 
Q2 Program contact available? 
o Yes  (1)  




Q3 Program name? 
o POLST  (1)  





















Q7 Legislative information available? 
o Yes  (1)  




Q8 Program website available? 
o Yes (please provide URL)  (1) ________________________________________________ 
o Yes, website available BUT not functioning  (2)  
o No  (3)  
 
Skip To: End of Block If Program website available? = Yes, website available BUT not functioning 
Skip To: End of Block If Program website available? = Yes, website available BUT not functioning 
Skip To: End of Survey If Program website available? = No 
 
Page Break  
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End of Block: Section 1 : POLST national program website scan 
 
Start of Block: Section 2: State's POLST website scan 
 
Q9 Does the POLST website offer Help-line / Contact number to ask questions? 
o Yes  (1)  
o No  (2)  




Q10 Able to view or print POLST form from the website? 
o Yes, able to view AND print  (1)  
o Sample / voided form available to view or print  (2)  
o No, sample form unavailable must request to see the form  (3)  
o Link available, but not functioning (Error message)  (4)  
o The website does not offer POLST form  (5)  
 
Skip To: End of Survey If Able to view or print POLST form from the website? = No, sample form unavailable must 
request to see the form 
Skip To: End of Survey If Able to view or print POLST form from the website? = Link available, but not functioning 
(Error message) 




Q11 POLST registry available? 
o Yes  (1)  
o No  (2)  
 





Q12 Able to upload a POLST form / search for a patient through registry? 
o Yes, able to upload a POLST form AND search for a patient through registry  (1)  
o Able to upload a POLST form, only  (2)  




Q13 Does the website offer additional information for patients or families? 
o Yes  (1)  




Q14 Does the website offer additional information on POLST program? (e.g. Brochures, Educational 
Videos)  
o Yes  (1)  
o No  (2)  
 
Skip To: Q16 If Does the website offer additional information on POLST program? (e.g. Brochures, Educational 
Vide... = No 
 
 
Q15 Please select resources available from the website (select all that apply) 
▢ Brochures on POLST program  (1)  
▢ Educational videos on POLST  (2)  






Q16 Does the website provide POLST form in different languages other than English? 
o Yes  (1)  
o No  (2)  
 





Q17 POLST form available in following languages? (Select all that apply) 
▢ Chinese (Traditional)  (1)  
▢ Chinese (Simplified)  (2)  
▢ Farsi  (3)  
▢ Hmong  (4)  
▢ Japanese  (5)  
▢ Korean  (6)  
▢ Pashto  (7)  
▢ Russian  (8)  
▢ Spanish  (9)  
▢ Tagalog  (10)  
▢ Vietnamese  (11)  
▢ Braille (available to request)  (12)  
▢ Arabic  (13)  
▢ Portuguese  (14)  
▢ Haitian Creole  (15)  
▢ Khmer  (16)  





End of Block: Section 2: State's POLST website scan 
 
Start of Block: Overview of POLST form 
 
Overview 1 Does the POLST form have a separate section for Future Hospitalization and Transfer to 
Hospital? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Does the POLST form have a separate section for Future Hospitalization and Transfer to 
Hospital? = No 
 
 
Overview 2 What are the options presented under Future Hospitalization / Transfer? 
▢ Do not transfer to the hospital  (1)  
▢ Do not transfer to the hospital unless pain or sever symptoms cannot be otherwise 
controlled  (2)  
▢ Transfer to the hospital  (3)  
▢ Transfer to the hospital, if necessary  (4)  
 
End of Block: Overview of POLST form 
 
Start of Block: Overview of POLST form - Intubation 
 
Intubation Q1 Does the POLST form have a separate section for Intubation and Mechanical Ventilation? 
o Yes  (1)  
o No  (2)  
 






Intubation Q2 What are the options presented under Intubation and Ventilation section? (Select all that 
apply) 
▢ Do not intubate (DNI)  (1)  
▢ Trial period - Intubation and Mechanical ventilation  (2)  
▢ Trial period - Noninvasive ventilation  (3)  
▢ Trial period - Noninvasive ventilation, if health care professional agrees that it is 
appropriate  (4)  
▢ Intubation and Mechanical ventilation  (5)  
▢ Intubation and long-term mechanical ventilation, if needed  (6)  
▢ Use Noninvasive ventilation  (7)  
▢ Do not use Noninvasive ventilation  (8)  
 
End of Block: Overview of POLST form - Intubation 
 
Start of Block: Section 3. Stat's POLST form scan 
 
Measures check Does the POLST form include Comfort Measures / Limited Measures / Full Measures 
section? 
o Yes  (1)  
o No  (2)  
 












Q18 Is the "Comfort Measures Only" section identical to the example above? 
o Yes  (1)  






Q19 Under the "Comfort Measures Only" section of the state's POLST form, what are the options 
included? (Select all that apply) 
▢ Medication  (1)  
▢ Medication by mouth only  (2)  
▢ Medication by any route  (3)  
▢ Positioning  (4)  
▢ Wound Care  (5)  
▢ Oxygen  (6)  
▢ Suction  (7)  
▢ Manual treatment of airway obstruction  (8)  
▢ Antibiotics  (9)  




Q20 Does "Comfort Measures Only" section indicate Transfer / Do not transfer to the hospital? 
o Yes  (1)  
o No  (2)  
 
Skip To: Limited Treatment If Does "Comfort Measures Only" section indicate Transfer / Do not transfer to the 





Q21 Under Comfort Measures Only, which are the options indicated for patient's hospital transfer? 
(Select all that apply) 
▢ "Do not transfer to hospital"  (1)  
▢ "Do not transfer to hospital for life-sustaining treatments"  (2)  
▢ "Transfer only if comfort needs cannot be met in current location"  (3)  
▢ "Patient prefers no transfer to hospital" or "Patient prefers no hospital transfer"  (4)  
▢ "Patient prefers no hospital transfer for life-sustaining treatments"  (5)  
▢ "Avoid calling 911"  (6)  
▢ "If possible, do not transport to ER"  (7)  
▢ "If possible, do not admit to the hospital from ER"  (8)  
 
 











Q22 Is the "Limited Treatment" section identical to the example above? 
o Yes  (1)  






Q23 Under the "Limited Treatment" section of the state's POLST form, what are the options included in 
addition to the Comfort Measures Interventions? (Select all that apply) 
▢ IV fluids  (1)  
▢ Cardiac Monitor  (2)  
▢ Antibiotics (PO / IV)  (3)  
▢ Less invasive airway support (CPAP, BiPAP)  (4)  
▢ Intubation, Mechanical Ventilation  (5)  
▢ Medication by mouth  (6)  
▢ Medication through a vein  (7)  
▢ Do not use intubation or mechanical ventilation  (8)  
▢ Interventions aimed at treatment of new or reversible illness / injury /non-threatening 
chronic condition  (9)  
▢ Not applicable - No options listed  (10)  
▢ Not applicable - options include other interventions such as use of Antibiotics / fluids / 
nutrition rather than specific activities  (11)  
▢ Oxygen  (13)  




Q24 Does "Limited Treatment" section indicate Transfer / Do not transfer to the hospital? 
o Yes  (1)  




Q25 Under "Limited Treatment" section, which are the options indicated for patient's hospital transfer?  
▢ Transfer to hospital if indicated  (1)  
▢ Transfer to hospital if indicated (AND) Avoid intensive care unit  (2)  
▢ Avoid intensive care unit / Generally avoid intensive care unit  (3)  
▢ Transfer to hospital for medical interventions  (5)  
▢ Transfer to hospital only if comfort needs cannot be met in current setting  (6)  
 
 











Q26 Is the "Full Treatment" section identical to the example above? 
o Yes  (1)  






Q27 Under the "Full Treatment" section of the state's POLST form, what are the options included in 
addition to the Comfort Measures Interventions and Limited Measures Interventions? (Select all that 
apply) 
▢ Intubation  (1)  
▢ Advanced airway interventions / Mechanical ventilation  (2)  
▢ Cardioversion  (3)  
▢ Use all medical / surgical intervention (e.g. all treatments)  (4)  
▢ IV fluids  (5)  
▢ No options listed under Full Treatment section  (7)  
▢ All needed treatment / All needed intervention  (8)  
▢ ICU only medication  (10)  
▢ Dialysis  (11)  
 
 





Q28 Does "Full Treatment" section indicate Transfer / Do not transfer to the hospital? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Does "Full Treatment" section indicate Transfer / Do not transfer to the hospital? = No 
 
 
Q29 Under "Full Treatment" section, which are the options indicated for patient's hospital transfer? 
(Select all that apply) 
o Transfer to hospital  (1)  
o Transfer to hospital and/or intensive care unit if indicated  (2)  
o Transfer to hospital if indicated, including Intensive care unit  (3)  
o No options listed under Full Treatment section  (4)  
 
 




End of Block: Section 3. Stat's POLST form scan 
 
Start of Block: Use of antibiotics, IV hydration and artificial nutrition 
 
Q30 Is there a separate section in the POLST form which focuses on the utilization of Antibiotics? 
o Yes  (1)  
o No  (2)  
 
Skip To: Q32 If Is there a separate section in the POLST form which focuses on the utilization of Antibiotics? = No 
 
 
Q31 What are the options indicated for the use of Antibiotics? (Select all that apply) 
▢ No antibiotics. Use other measures to relieve symptoms  (1)  
▢ Use antibiotics only to relieve pain and discomfort  (2)  
▢ Determine use or limitation of antibiotics when infection occurs, with comfort as goal  
(3)  
▢ Trial period of antibiotics when infection occurs / to treat infection  (4)  
▢ Use antibiotics if medically indicated  (5)  
▢ Use antibiotics if life can be prolonged / to preserve life  (6)  
▢ Antibiotics by IV  (7)  
▢ Antibiotics by PO  (8)  
▢ Antibiotics  (9)  
▢ Use antibiotics consistent with treatment goals  (11)  
▢ Use antibiotics for infection only if comfort cannot be achieved fully through other 






Q32 Is there a section for either artificially administered fluids / hydration OR artificially administered 
nutrition? 
o Yes, there is a section for either artificially administered fluids / hydration OR artificially 
administered nutrition  (1)  
o Only Artificially administered fluids / hydration  (2)  
o Only Artificially administered nutrition  (3)  
o POLST form does not contain either section  (4)  
 
Skip To: Q33 If Is there a section for either artificially administered fluids / hydration OR artificially admini... = Yes, 
there is a section for either artificially administered fluids / hydration OR artificially administered nutrition 
Skip To: End of Block If Is there a section for either artificially administered fluids / hydration OR artificially admini... 
= POLST form does not contain either section 
Skip To: Q34-B If Is there a section for either artificially administered fluids / hydration OR artificially admini... = 
Only Artificially administered fluids / hydration 
Skip To: Q35 If Is there a section for either artificially administered fluids / hydration OR artificially admini... = Only 
Artificially administered nutrition 
 
 
Q33 Are there two separate sections for artificially administered fluids / hydration and artificially 
administered nutrition?  
o Yes, there are two separate sections  (1)  
o No, artificially administered fluids and nutrition options located under ONE section  (2)  
 
Skip To: Q34 If Are there two separate sections for artificially administered fluids / hydration and artificially... = Yes, 
there are two separate sections 
Skip To: Q36 If Are there two separate sections for artificially administered fluids / hydration and artificially... = No, 





Q34 What are the options indicated for the use of artificially administered fluids / hydration? (Select all 
that apply) 
▢ No feeding tube  (1)  
▢ No feeding tube, initially  (2)  
▢ No IV fluids  (3)  
▢ No IV fluids, initially  (4)  
▢ Trial period of artificial fluid / hydration via feeding tube  (5)  
▢ Trial period of IV hydration  (6)  
▢ Full / long term fluids / hydration via feeding tube  (7)  
▢ Full / long term IV hydration  (8)  
▢ Other (please specify)  (9) ________________________________________________ 
 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = No 
feeding tube 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = No 
feeding tube, initially 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = No 
IV fluids 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = No 
IV fluids, initially 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = 
Trial period of artificial fluid / hydration via feeding tube 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = 
Trial period of IV hydration 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = 
Full / long term fluids / hydration via feeding tube 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = 
Full / long term IV hydration 
Skip To: Q35 If What are the options indicated for the use of artificially administered fluids / hydration? (Sele... = 





Q34-B What are the options indicated for the use of artificially administered fluids / hydration? (Select all 
that apply) 
▢ No feeding tube  (1)  
▢ No feeding tube, initially  (3)  
▢ No IV fluids  (4)  
▢ No IV fluids, initially  (5)  
▢ Trial period of artificial fluid / hydration via feeding tube  (7)  
▢ Trial period of IV hydration  (8)  
▢ Full / long term fluids / hydration via feeding tube  (9)  
▢ Full / long term IV hydration  (10)  
▢ Other (please specify)  (11) ________________________________________________ 
 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = No feeding tube 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = No feeding tube, initially 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = No IV fluids 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = No IV fluids, initially 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = Trial period of artificial fluid / hydration via feeding tube 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = Trial period of IV hydration 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = Full / long term fluids / hydration via feeding tube 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 
(Sele... = Full / long term IV hydration 
Skip To: End of Block If What are the options indicated for the use of artificially administered fluids / hydration? 





Q35 What are the options indicated for the use of artificially administered nutrition? (Select all that apply) 
▢ No tube feeding / No artificial nutrition, including tube feeding  (1)  
▢ No tube feeding - Initially  (2)  
▢ Defined trial / short term period of artificial nutrition by feeding tube  (3)  
▢ Long-term / permanent artificial nutrition by tube  (4)  
▢ Artificial nutrition, unless it provides no benefit  (5)  
▢ No TPN  (6)  
▢ No TPN - Initially  (7)  
▢ TPN for a trial period  (8)  
▢ TPN long-term  (9)  
 
Skip To: End of Block If What are the options indicated for the use of artificially administered nutrition? (Select all 
th... = No tube feeding / No artificial nutrition, including tube feeding 
Skip To: End of Block If What are the options indicated for the use of artificially administered nutrition? (Select all 
th... = No tube feeding - Initially 
Skip To: End of Block If What are the options indicated for the use of artificially administered nutrition? (Select all 
th... = Defined trial / short term period of artificial nutrition by feeding tube 
Skip To: End of Block If What are the options indicated for the use of artificially administered nutrition? (Select all 





Q36 What are the options under artificially administered fluids AND nutrition? 
▢ No feeding tube (e.g. No artificial nutrition or hydration by tube)  (1)  
▢ No IV fluids  (2)  
▢ A trial period of feeding tube (either hydration or nutrition)  (11)  
▢ A trial period of IV fluids  (3)  
▢ Artificial nutrition and hydration (with no indication for period)  (12)  
▢ Long term feeding tube (fluids, artificial nutrition by tube)  (4)  
▢ Long term IV fluids  (13)  
 
 




End of Block: Use of antibiotics, IV hydration and artificial nutrition 
 
Start of Block: Signing of the POLST form 
 
Q37 Clinicians authorized to sign the form (select all that apply) 
▢ Medical Doctor (M.D)  (1)  
▢ Doctor of Osteopathic Medicine (D.O)  (2)  
▢ Advanced Practice Registered Nurse (APRN) / Nurse Practitioner (NP)  (3)  
▢ Physician Assistant (P.A)  (4)  
▢ "Licensed provider" (specific titles not provided)  (5)  
▢ Licensed resident  (6)  
▢ Licensed resident (second year or higher)  (7)  




















Appendix C. Physician Orders for Life-Sustaining Treatment (POLST) Sample Form 
 
 131 
 
 
